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 EFFORTS TOWARDS THE TOTAL SYNTHESIS OF AMPHIDINOLIDE B 
Apsara Gopalarathnam, Ph.D 
University of Pittsburgh, 2006
 
Studies towards the total synthesis of the cytotoxic marine macrolide Amphidinolide B have 
been disclosed. Catalytic asymmetric AAC methodology has been applied to efficiently generate 
the C11- and the C18- stereocenters in the requisite fragments 114 and 120 through β-lactones 102 
and 81 respectively. 
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An efficient route to install the C14-C15 trisubstituted alkene was realized through a 
stannylcupration reaction. The Stille and Suzuki cross-coupling methodologies were investigated 
for the formation of the C13-C15 diene of amphidinolide B. Iodide 90 was coupled with boronic 
 iii 
ester 114 via an efficient Suzuki reaction to form a C7-C20 fragment 115. Fragment was further 
homologated and coupled to sulfone 65 to complete a C1-C20 synthon of amphidinolide B. 
 
N
OTBSO
Me
MeTBSO
OMe
I
Me
Me
Bpin
OTBS
O114
30 mol % Pd(dppf)Cl2
3.0 Ba(OH)2
DMF, 45 °C
MeTBSO OTBSO
N
OMeMe
Me
OTBS
O 115
Me
MeTBSO OTBSO
N
Me
OMeMe
Me
O
CO2TMSE
Me
117
1. HF/py
2. Dess-Martin oxd.
3. KHMDS, 65,
 –55 °C
90
 
 
 iv 
TABLE OF CONTENTS 
 
1.0 THE FIRST GENERATION APPROACH .............................................................. 1 
1.1 BACKGROUND.................................................................................................. 1 
1.1.1 Isolation.......................................................................................................... 1 
1.1.2 Structural Features and Biological Activity ............................................... 3 
1.1.3 Previous Approaches to the Total Synthesis of Amphidinolide B............ 5 
1.2 APPLICATION OF THE AAC METHODOLOGY TO THE TOTAL 
SYNTHESIS OF AMPHIDINOLIDE B .......................................................................... 13 
1.3 RETROSYNTHETIC ANALYSIS .................................................................. 15 
1.4 SYNTHESIS OF THE C7–C13 FRAGMENT .................................................. 16 
1.4.1 Retrosynthetic analysis............................................................................... 16 
1.4.2 Synthesis of Triflate 67 ............................................................................... 17 
1.5 SYNTHESIS OF THE C1–C6 SULFONE FRAGMENT ............................... 19 
1.6 SUMMARY........................................................................................................ 20 
EXPERIMENTAL SECTION .......................................................................................... 21 
2.0 THE DIENE PROBLEM: SOLUTION IN A MODEL SYSTEM ........................ 34 
2.1 INTRODUCTION ............................................................................................. 34 
2.2 INSTALLATION OF THE C16- AND C18- STEREOCENTERS ................. 34 
2.2.1 Retrosynthetic analysis of fragment 68..................................................... 34 
2.3 INSTALLATION OF THE C14–C15 TRISUBSTITUTED ALKENE .......... 36 
2.4 STILLE COUPLING STUDIES ...................................................................... 39 
2.4.1 Standard conditions .................................................................................... 39 
2.4.2 Coupling under modified Stille conditions ............................................... 39 
2.4.3 Summary of Stille coupling studies ........................................................... 42 
 v 
2.5 SUZUKI COUPLING STUDIES ..................................................................... 43 
2.5.1 Attempted transmetalation of vinyl iodide fragment 90 ......................... 43 
2.5.2 Attempted modification of triflate fragment 67....................................... 44 
2.5.3 Synthesis of model boronic acid/ester compounds................................... 45 
2.5.4 Suzuki trials in the model system .............................................................. 47 
2.6 SUMMARY........................................................................................................ 48 
EXPERIMENTAL SECTION .......................................................................................... 49 
3.0 COMPLETION OF A C1–C20 FRAGMENT AND THE SECOND 
GENERATION APPROACH.................................................................................................... 63 
3.1 ALTERNATE SYNTHESIS OF THE C7–C13 FRAGMENT........................ 63 
3.2 DIENE FORMATION IN THE REAL SYSTEM.......................................... 64 
3.2.1 Suzuki coupling studies with the C7–C13 fragment.................................. 64 
3.2.2 Diene instability under Sharpless’ epoxidation conditions ..................... 66 
3.2.3 Modification of the epoxide fragment and completion of the C7–C20 
fragment...................................................................................................................... 66 
3.2.4 Completion of a C1–C20 synthon................................................................ 68 
3.3 SHORTCOMINGS OF THE FIRST GENERATION APPROACH........... 69 
3.3.1 Completion of the C14–C26 fragment ......................................................... 69 
3.3.2 Sensitivity of the C21- α-keto stereocenter ................................................ 71 
3.4 THE SECOND GENERATION APPROACH TO AMPHIDINOLIDE B- 
THE ALDOL STRATEGY ............................................................................................... 72 
3.4.1 Revised retrosynthesis- homologation through Weinreb amide 90 ....... 72 
3.4.2 Synthesis of precursors for aldol study..................................................... 74 
3.4.3 Glycolate aldol trials ................................................................................... 75 
3.5 THE DITHIANE ROUTE FOR FRAGMENT COUPLING ........................ 76 
3.5.1 Alternate coupling strategy to form the C14–C26 fragment..................... 76 
3.5.2 Synthesis of aldehyde fragment 130 and dithiane 129............................. 77 
3.5.3 Dithiane reaction trials ............................................................................... 79 
3.6 CONCLUSIONS................................................................................................ 80 
EXPERIMENTAL SECTION .......................................................................................... 80 
BIBLIOGRAPHY..................................................................................................................... 105 
 vi 
LIST OF TABLES 
Table 1. Cytotoxic activities of amphidinolide B and related compounds ..................................... 4 
Table 2: Modified Stille coupling studies..................................................................................... 43 
 vii 
LIST OF FIGURES 
Figure 1. Amphidinolide B (1)........................................................................................................ 1 
Figure 2. The amphidinolide B congeners...................................................................................... 2 
Figure 3. Chakraborty's approach to the synthesis of fragments of amphidinolide B .................... 6 
Figure 4. Nishiyama's approach to amphidinolide B fragments ..................................................... 7 
Figure 5.  Lee's retrosynthesis of fragments of amphidinolide B ................................................... 8 
Figure 6. Pattenden's approach to the synthesis of amphidinolide B.............................................. 9 
Figure 7.  Kobayashi efforts towards the synthesis of amphidinolide B ...................................... 10 
Figure 8. Myles' approach towards the synthesis of amphidinolide B ......................................... 11 
Figure 9. Carter's approach to the C9-C26 fragment of amphidinolide B...................................... 12 
Figure 10: Retrosynthesis of major fragments of amphidinolide B by Crews ............................. 13 
Figure 11: The use of β-lactones as versatile synthons ................................................................ 14 
Figure 12: Retrosynthetic analysis of Amphidinolide B............................................................... 16 
Figure 13: Retrosynthetic analysis of the C7-C13 fragment .......................................................... 17 
Figure 14: Retrosynthetic analysis of fragment 68 ....................................................................... 35 
Figure 15: Revised retrosynthetic analysis of Amphidinolide B- the aldol approach .................. 73 
Figure 16: Retrosynthesis of the C14–C26 fragment- the dithiane approach ................................. 77 
 viii 
LIST OF SCHEMES 
Scheme 1. Synthesis of the C7–C13 subunita ................................................................................. 19 
Scheme 2. Synthesis of C1–C6 Subunita ....................................................................................... 20 
Scheme 3: Installation of the C16- and C18- stereocentersa ........................................................... 36 
Scheme 4: Synthesis of alkyne substrate for carbometalation studiesa ........................................ 37 
Scheme 5: Carbostannylation studies on alkyne 87a .................................................................... 38 
Scheme 6: The Corey-modified Stille trials on model system ..................................................... 40 
Scheme 7: The Farina-modified Stille reaction trials on model system ....................................... 41 
Scheme 8: Attempted conversion of iodide 90 to boronic acid .................................................... 44 
Scheme 9: Synthesis of model boronate ester from S-(-)-citronellala .......................................... 46 
Scheme 10: Synthesis of model boronic acid from S-(-)-citronellala ........................................... 46 
Scheme 11: Alternate synthesis of the C7–C13 fragmenta ............................................................. 64 
Scheme 12: Sharpless' epoxidation of allylic alcohol 112............................................................ 66 
Scheme 13: Completion of a C7–C20 fragment of amphidinolide Ba............................................ 68 
Scheme 14: Elaboration of 115 to a C1–C20 synthona................................................................... 69 
Scheme 15: Synthesis of the C14–C26 fragmenta........................................................................... 70 
Scheme 16: Lability of the C21 stereocenter ................................................................................. 72 
Scheme 17: Synthesis of precursor 124 for aldol studya .............................................................. 74 
Scheme 18: Synthesis of aldehyde 130 for dithiane trialsa........................................................... 78 
 ix 
LIST OF ABBREVIATIONS 
DCC                     1,3-dicyclohexylcarbodiimide 
DDQ                  2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
(DHQ)2PHAL      dihydroquinine 1,4-phthalazinediiyl diether 
DEPT                   Distortionless Enhancement by Polarization Transfer 
DIAD                   diisopropylazodicarboxylate 
DMAP                  2-(dimethylamino)pyridine 
DME                    1,2-dimethoxyethane 
DMF                    dimethylformamide 
dppf                      1,1’-bis(diphenylphosphino)ferrocene 
EDCI                    1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride                    
EDTA                   ethylenediaminetetraacetic acid 
HMPA                  hexamethylphosphoramide 
nOe                       nuclear Overhauser effect 
TBAF                    tetrabutylammoniumfluoride 
TBSOTf                tert-butyldimethylsilyl triflate 
TFA                       trifluoroacetic acid 
TMSCl                  trimethylsilylchloride 
 x 
ACKNOWLEDGEMENTS 
 
I am thankful to God Almighty for giving me the strength to pursue graduate school to obtain an 
advanced degree.  
 
My thanks are due to my advisor Scott Nelson, for being a great teacher, mentor and giving me 
the opportunity to work on such an interesting and challenging project. He has offered excellent 
guidance and support in the project as well as outside; in making his students understand 
fundamental concepts. 
 
I would like to thank all the members of the Nelson group, past and present, for friendship and 
good company. In particular, I would like to thank Andrew Kassick, who worked with me on my 
project, and was a great source of inspiration. Post-doctoral associates Chris Bungard and Cheng 
Zhu were excellent mentors in my first three years and not only taught me skills, but maintained 
a lively atmosphere at work. My special thanks are due to Ben Stevens for great moral support in 
times of trouble and good friendship. I would also like to thank Magda, Andrew, Xiaoqiang, 
Nessan and Jeremy for nice company at work and during the many group lunches. 
 
 xi 
I would like to thank Siva, Raghu and Vasu for wonderful friendship and I will always cherish 
the great times I have had with them. I would also like to thank Dhanalakshmi for being a really 
good friend and being of great help in my final year. 
 
My parents and my brothers have been extremely supportive in the last five years and I could not 
have made it through without their inspiration and constant words of advice. I am truly blessed to 
have them as my family.  
 
I would like to thank my husband Hari, for his constant source of moral support, good advice, for 
patiently listening to my complaints, especially in the last few months and… just for being there. 
I consider myself very lucky to be his wife. 
 
 
 
 
 
 
 xii 
1.0  THE FIRST GENERATION APPROACH 
1.1 BACKGROUND 
1.1.1 Isolation  
The amphidinolides are a series of macrocyclic natural products which have shown to 
have potential cytotoxic activity. These have been isolated as secondary metabolites from marine 
dinoflagellates of the genus Amphidinium, which are symbionts of the Okinawan flatworm 
Amphiscolops sp. [1] Amphidinolide B (1) is among the most biologically significant and 
structurally interesting molecules in this class of macrolides. 
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Figure 1. Amphidinolide B (1) 
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Amphidinolide B was first discovered in 1987 by the research group of Kobayashi in the 
strain Y-5 from the cultured dinoflagellate of the flatworm Amphiscolops Breviviridis. Later, 
Shimizu and coworkers isolated three amphidinolide B congeners, namely amphidinolides B1, 
B2 (2) and B3 (3) from a free-swimming dinoflagellate Amphidinium operculatum ver nov 
Gibbosum. [1] Amphidinolide B1 was shown to be identical in all respects to amphidinolide B 
whereas 2 was shown to be its C18- epimer and 3, the C22- stereoisomer of 1 (Figure 2). More 
recently, a strain Y-71 of the genus Amphidinium has been shown to yield a relatively large 
amount of amphidinolide B. 
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Figure 2. The amphidinolide B congeners 
 
Structural investigations concurrent with the isolation efforts of amphidinolide B were 
undertaken by both the groups of Kobayashi and Shimizu which lead to proof of relative 
stereochemistry through an X-ray crystal structure. [2] Subsequently, absolute stereochemistry 
was also determined via chemical degradation studies leading to the C22–C26 subunit, and by 
comparing its spectral and HPLC data with those of the same compound that was independently 
synthesized. [3]  
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1.1.2 Structural Features and Biological Activity 
The family of amphidinolides exhibits structural diversity including variations in the ring 
size of the macrolactone from 19 [amphidinolide E] to 27 [amphidinolide G]. The amphidinolide 
B group of molecules i.e. 1, 2 and 3 shares its 26-membered lactone feature with the structurally 
similar amphidinolide H- type macrolides.  
 
Amphidinolide B possesses a very unique arrangement of functionality in its backbone. 
The top half of the molecule i.e. the C14–C26 portion bears four hydroxyl groups in addition to a 
C20- ketone carbon and can be termed as the “hydrophilic” domain of the molecule. On the other 
hand, the C1–C13 or the “hydrophobic” portion of the molecule contains relatively fewer oxygen 
bearing carbons, save for the C8–C9 epoxide and an ester linkage.  The molecule features a total 
of nine stereogenic centers which include a tertiary alcohol center at C16, the C21–C22 syn diol 
relationship, in addition to two isolated methyl bearing stereocenters. Perhaps the most 
interesting structural features from a synthetic standpoint are the presence of a potentially acid 
sensitive exocyclic 1, 3- diene unit in the C13–C15 portion and the C8–C9 allylic epoxide moiety. 
 
Amphidinolide B has been shown to have a rectangular shape as revealed in the X-ray 
crystal structure, this shape being dictated by the presence of a 2 Å hydrogen bond between the 
C21- hydroxyl and the epoxide oxygen linking the C8–C9 bond (Figure 1).2 The solution 
conformation in chlorinated solvents seems to be close to the crystal conformation as indicated 
by the matching of spin-spin coupling constants and those calculated from dihedral angles 
obtained from crystal structure. This may hold some significance to the exceptional levels of 
cytotoxicity exhibited by this molecule.  
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 Biological assays have placed amphidinolide B as among of the most cytotoxic in the 
family of amphidinolides. [1,4] It displays IC50 values of 0.14 ng/mL against the L1210 murine 
leukemia cell line, 0.12 μg/mL against the human colon tumor HCT 116 cell line and 4.2 ng/mL 
against the KB cancer cell line. The importance of the C21- hydroxyl group is revealed by the fact 
that the epimer at that carbon, amphidinolide D, is 100 times less cytotoxic than amphidinolide B 
(Table 1). The presence of the epoxide was found to be critical owing to the fact that the 
epoxide-opened derivative of 1 obtained by methanolysis was found to have 1/600th of its 
activity against the L1210 cell line. Amphidinolide H, which has a very similar X-ray crystal 
structure as 1, exhibits similar levels of cytotoxicity thus stressing the link between conformation 
and bioactivity. 
 
Table 1. Cytotoxic activities of amphidinolide B and related compounds [1a] 
   Compounds                              IC50 a/μg mL-1
                                                       (L1210)b           (KB)c
amphidinolide B (1)              0.00014      0.0042
amphidinolide D                   0.019          0.08
amphidinolide H                   0.0004        0.00052
epoxide-opened
derivative of 1                       0.081             -
a 50% inhibition concentration. b Murine lymphoma cell
c Human epidermoid carcinoma cells  
 
Although assays have been performed to determine its biological activity, there have 
been no reports about the mechanism of action of amphidinolide B. Sparse amounts available 
 4 
from natural sources and the lack of a total synthesis of the compound have severely hindered 
such studies. The synthetic community at large has been interested, for almost ten years, in 
achieving a total synthesis of this molecule. To date, a complete synthesis has not been reported; 
however, many partial syntheses have been communicated. 
1.1.3 Previous Approaches to the Total Synthesis of Amphidinolide B 
Chakraborty reported the first approach towards the total synthesis of amphidinolide B 
(1) in his stereoselective synthesis of the upper fragment 4 (Figure 3). This was achieved via an 
aldol bond construction across the C18–C19 bond between aldehyde 5 and methyl ketone 6. The 
C16- stereocenter in aldehyde 5 was formed by Sharpless asymmetric epoxidation of allylic 
alcohol 7, and Sharpless dihydroxylation of unsaturated ester 8 (syn:anti 3:1) set the syn-diol 
relationship across the C21–C22 bond. [5] Key steps in the synthesis of lower fragment 9 include a 
Nozaki-Hiyama-Kishi reaction to couple aldehyde 10 and vinyl iodide 11 (syn:anti 3:7); an 
Evans’s alkylation reaction was used to set the C11- stereocenter in aldehyde fragment 10 and a 
Wittig reaction subsequently formed the E-enoate ester. [6] 
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Figure 3. Chakraborty's approach to the synthesis of fragments of amphidinolide B 
 
Nishiyama published his synthesis of the upper fragment 12 that involves the addition of 
the anion of dithiane 14 to iodide 13, wherein the C16- stereocenter in iodide 13 is set by an 
alkynyl opening of the methylketone derived from ester 15 and aldehyde 16 is homologated to 
dithiane 14 (Figure 4). [7] A Claisen rearrangement and a Wittig reaction were used in the 
synthesis of lower fragment 17. The methyl bearing C11- stereocenter in fragment 18 was set by 
Evan’s alkylation protocol and (D)-erythrose-derived diol 19 served as the source for the C8- and 
C9- stereocenters. [8]  
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Figure 4. Nishiyama's approach to amphidinolide B fragments 
 
Around the same time as Nishiyama’s investigations, independent studies were 
conducted by Lee who synthesized upper fragment 20 by the addition of a vinyl-lithium species 
generated from 22 to aldehyde 21 in which the C16- stereocenter is generated via a Sharpless 
epoxidation and subsequent opening with a methylcuprate (Figure 5). [9] The C18- stereocenter 
is set by a regioselective opening of epoxide 25 by cuprate derived from vinyl bromide 24. A 
later publication in 2000 describes the synthesis of lower fragment 26 wherein the C11- methyl 
bearing stereocenter is set using Myers’ chiral auxiliary. [10] A Sharpless epoxidation reaction 
on allylic alcohol 27 formed the C8–C9 epoxide functionality and subsequent homologation via a 
Horner-Wadsworth-Emmons reaction completed fragment 26. 
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Figure 5.  Lee's retrosynthesis of fragments of amphidinolide B 
 
In his 1998 publication, Pattenden disclosed his approach of making the C14–C26 fragment 
28, in which the requisite trisubstituted alkene functionality was installed in aldehyde 29 before 
its aldol coupling with ketone partner 30 with 3:2 diastereoselectivity (Figure 6). [11] Vinyl 
iodide 29 was made by silyl-stannation of terminal alkyne 31 followed by introduction of the 
methyl group via a cuprate reaction. The C16- stereocenter was formed by opening of epoxide 
derived form alcohol 32 and pentane-2,4-diol served as the precursor for ketone 30. Notable 
steps in the synthesis of lower fragment 33 include a Julia olefination between epoxy aldehyde 
34 and sulfone 35. [12] (R)-Methylglutarate 36, containing the preexisting C11-stereocenter, 
served as the precursor to aldehyde 34. An intermolecular macrolactonization reaction linked the 
C1–C13 fragment 28 to the C14–C26 fragment 33; however, efforts to effect an intramolecular 
Stille reaction for the construction of the C13–C14 bond were unsuccessful. 
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Figure 6. Pattenden's approach to the synthesis of amphidinolide B 
 
Published in 1999, Kobayashi’s synthetic approach to the synthesis of the C14–C26 
fragment 37, shares common features with Chakraborty’s and Pattenden’s in that the aldol 
disconnection is used for the C18–C19 bond construction (Figure 7). [13] The C16- tertiary alcohol 
stereocenter in aldehyde 38 is set using Sharpless’ asymmetric dihyroxylation, so also is the syn-
diol relationship of the C21–C22 bond in ketone 39.  Lower fragment 40 is made by the addition 
of alkyne 42 to aldehyde 41. [14] (2S,4S)-Pentane-2,4-diol served as the common precursor for 
methyl ketone 39 and aldehyde 41. 
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Figure 7.  Kobayashi efforts towards the synthesis of amphidinolide B 
 
Also in 1999, Myles synthesized the aldehyde equivalent of the upper fragment synthon 
43 by coupling phosphonate ester 44 made from gereniol epoxide 45 with aldehyde 46        
(Figure 8). [15] Lower fragment 47 is the product of a Julia olefination of ester 48 and sulfone 
49. [16] Alcohol 50 derived from L-lactate was used as the common precursor for aldehyde 46 
and ester 48. 
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Figure 8. Myles' approach towards the synthesis of amphidinolide B 
 
Since 2004, there has been renewed interest in the synthetic community in realizing the 
goal of a total synthesis of one of the amphidinolide B- type molecules. Carter has recently 
reported an efficient synthesis of a C9–C29 fragment 51 by employing a highly diastereoselective 
aldol reaction between the lithium enolate of ketone 53 and aldehyde 52 to set the C18–
stereocenter (Figure 9). [17]  The 1, 1- disubstituted alkene in 53 was formed by dehydration of 
the alcohol formed by the allylation of methyl ketone 54 by allyl silane 55. Methyl ketone 53 
was formed from aldehyde 56 by application of Evans’ aldol reaction and the C16- tertiary 
alcohol center is set by Seebach alkylation methodology. 
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Figure 9. Carter's approach to the C9-C26 fragment of amphidinolide B 
 
More recently, Crews has reported the synthesis of three major fragments of 
amphidinolide B (Figure 10). [18] Fragment 57 was formed from methyl ketone 59 by a Horner-
Wadsworth-Emmons reaction in which the C16- stereocenter was set via Sharpless epoxidation 
followed by hydride opening. Synthesis of fragment 58 utilizes a stereoselective methallylsilane 
addition into aldehyde 60 followed by a Johnson ortho ester Claisen rearrangement. Key steps in 
making fragment 61 include a diastereoselective methylation of aldehyde 62 by Seebach’s 
protocol and rhenium oxo catalysis to effect 1, 3-isomerization of the allylic alcohol in the 
resulting adduct.   
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Figure 10: Retrosynthesis of major fragments of amphidinolide B by Crews 
1.2 APPLICATION OF THE AAC METHODOLOGY TO THE TOTAL SYNTHESIS 
OF AMPHIDINOLIDE B 
In the Nelson group, catalytic asymmetric methodology has been developed to prepare 
highly enantioenriched β-lactones from a wide range of aldehydes. [19] The use of 
substoichiometric amounts (10–15 mol %) of chiral aluminum triamine catalyst 63 in the 
asymmetric acyl-halide aldehyde cyclocondensation (AAC) provides optically active β-lactones 
(Eq 1). These easily prepared β-lactones serve as masked aldol adducts and have been employed 
as useful synthons in natural product syntheses. [20] 
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A variety of stereochemical relationships can be accessed from these optically active β-
lactones. Addition of hard nucleophiles such as alkyl Grignard reagents and metal amides into 
the carbonyl of the β-lactones affords products with a hydroxyl- bearing stereocenter (Figure 11). 
Soft nucleophiles such as cuprates, on the other hand, open the β-lactones at the C4 position in an 
SN2 fashion to yield products with alkyl-bearing stereocenters. Apart from accessing 1, 3- 
stereochemical relationships in compounds possessing carbonyl functional groups, these 
reactions can be used to set isolated stereocenters as well.  
 
RNuc
O OH O
O
R
RHO
O NucNuc =
R2CuLi
Nuc =
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Figure 11: The use of β-lactones as versatile synthons 
 
Amphidinolide B possesses an isolated methyl bearing stereocenter at C11 and a 
hydroxyl- bearing stereocenter at C18 which could potentially be synthesized via our AAC 
methodology. We decided to undertake the synthesis of this natural product to investigate the 
N
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challenges associated with it as well as to explore the applicability of our methodology in the 
context of a complex molecule synthesis.  
1.3 RETROSYNTHETIC ANALYSIS 
Our retrosynthetic analysis of amphidinolide B is based on the novel approach of creating 
strategic stereocenters using our AAC methodology. Recognizing the lability of the allyl-epoxide 
moiety in amphidinolide B, we elected to incorporate this functional group late in the synthesis. 
The major disconnections in the molecule are across the C1–O bond via macrolactonization and 
the C6–C7 bond by Julia olefination reactions respectively, to arrive at precursors, aldehyde 64 
and the corresponding sulfone fragment 65 (Figure 12). We envisioned that the diene moiety in 
fragment 64 could be installed via a Stille or Suzuki reaction between a vinyl metal (stannane or 
boronate) fragment 66- the “upper fragment” synthon and triflate 67. Further disconnection at the 
C21–C22 bond in fragment 66 showed that it could be made via a Horner–Wadsworth–Emmons 
olefination reaction between enantioenriched aldehyde 69 and phosphonate ester 68.  
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Figure 12: Retrosynthetic analysis of Amphidinolide B 
 
1.4 SYNTHESIS OF THE C7–C13 FRAGMENT 
1.4.1 Retrosynthetic analysis 
We envisioned that the C11- methyl bearing stereocenter in the “lower left” triflate 
fragment 67 could be made by application of our AAC methodology. We aimed to prepare 
triflate 67 from carboxylic acid 71 via intermediate diol 70. Carboxylic acid 71 can be made 
from β-lactone 72 via a cuprate ring opening reaction (Figure 13). Lactone 72 would be the 
product of cyclocondensation on aldehyde 73 which in turn is produced from enantiomerically 
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enriched β-lactone 74. Although the stereochemical information in aldehyde 73 would be 
ultimately destroyed in the formation of triflate 67, it is required in order to obtain good 
diastereoselectivity in the subsequent cyclocondensation reaction. Previous studies have shown 
that an optically active β-silyloxy aldehyde gives rise to double diastereoselection in the AAC 
reaction [21] and we decided to prepare the (S)-enantiomer of aldehyde 73 since it would be 
matched with chiral (S,S)-catalyst 63.  
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Me
OTBSO
O
Me
OTBSO
H
O
O
Me
67 70
71
7274 73  
Figure 13: Retrosynthetic analysis of the C7-C13 fragment 
 
1.4.2 Synthesis of Triflate 67 
In order to execute the above mentioned scheme, β-lactone 74 was prepared by an 
asymmetric AAC reaction with acetaldehyde in 89% yield and greater than 98% enantiomeric 
excess (Scheme 1). Ring-opening of 74 with N,O-dimethylhydroxylamine and 
dimethylaluminum chloride followed by protection of the resulting alcohol with a tert-
butyldimethylsilyl group gave Weinreb amide 75 in an overall 60% yield. Amide 75 was 
efficiently reduced by diisobutylaluminum hydride to give aldehyde 76 in 91% yield. Subsequent 
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cyclocondensation reaction of aldehyde 76 with acetyl bromide using optically active catalyst 63 
afforded β-lactone 72 in a yield of 82% and excellent syn:anti diastereoselection of 35:1 as 
determined by 500 MHz 1H NMR analysis. Cuprate mediated ring-opening of β-lactone 72 
proceeded in 71% yield to give carboxylic acid 71 which then underwent a one-step reduction-
oxidation sequence, developed by Brown, [22] to afford aldehyde 77 in 85% yield. Horner-
Wadsworth-Emmons olefination [23] of aldehyde 77 followed by diisobutylaluminum hydride 
mediated over-reduction and deprotection of the tert-butylsilyl group produced diol 70 in 62% 
overall yield over two steps. Selective protection of the primary alcohol in diol 70 with a 
triisopropylsilyl group proceeded smoothly followed by oxidation of the secondary alcohol by 
PCC to afford ketone 78 in 80% yield over two steps. Ketone 78 was then converted into triflate 
67 with N-phenyltriflimide in 76% yield, [24] thus completing the synthesis of the “lower left” 
fragment of amphidinolide B. 
 
 
 
 
 
 
 
 
 
 
  
 18 
Scheme 1. Synthesis of the C7–C13 subunita 
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1.5 SYNTHESIS OF THE C1–C6 SULFONE FRAGMENT  
The requisite sulfone fragment 65 was synthesized from γ-butyrolactone in a short 
sequence commencing with reduction to the lactol and in situ Wittig olefination with 
phosphonium salt 79 to obtain alcohol 80 in 70% yield (Scheme 2). [25,26] Subsequently, a 
Mitsunobu reaction was used to introduce the phenyltetrazole thiol group (DIAD, PPh3, DMF) 
which was then oxidized to the sulfone functionality with ammonium molybdate and 30% 
hydrogen peroxide. The tert-butyl carboxylate was then exchanged for the more labile 
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trimethylsilylethyl protecting group by removal of the tert-butyl group by TFA and esterification 
with trimethylsilylethanol to make sulfone 65 (64% for 4 steps).  
 
Scheme 2. Synthesis of C1–C6 Subunita
CO2TMSE
MePTO2S
65
O
O
CO2tBu
MeOH
O
OH Ph3P CO2tBu
Me
a
b
79
80
aConditions: (a) iBu2AlH,CH2Cl2; ii. 79, THF. (b) phenyltetrazolethiol, 
DIAD, PPh3, DMF; ii. H2O2, (NH4)6Mo7O24.7H2O, 30% H2O2 ; 
iii. TFA, CH2Cl2/anisole ; iv.  2-trimethylsilylethanol, 
DCC, DMAP, CH2Cl2.
64%
70%
 
1.6 SUMMARY 
Towards the synthesis of amphidinolide B, an asymmetric synthesis of triflate fragment 
67 was achieved by employing the AAC methodology. Sulfone fragment 65 was also made in a 
short sequence starting from γ-butyrolactone. An efficient synthesis of the C14–C26 fragment and 
formation of the C13–C15 diene unit were identified as the next important goals in the project. 
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EXPERIMENTAL SECTION 
General Information: Optical rotations were measured on a Perkin-Elmer 241 digital 
polarimeter with a sodium lamp at ambient temperature and are reported as follows: [α]λ (c 
g/100 mL). Infrared spectra were recorded on a Nicolet Avatar 360 FT-IR spectrometer. 1H 
NMR spectra were recorded on Bruker DPX 301/302 (300 MHz) spectrometers.Chemical shifts 
are reported in ppm from tetramethylsilane with the solvent resonance as internal standard 
(CHCl3: δ 7.27 ppm). Data are reported as follows: chemical shift, multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet), coupling constants (Hz), integration. 13C NMR 
spectra were recorded on Bruker DPX 301/302 (75 MHz) spectrometers with complete proton 
decoupling. Chemical shifts are reported in ppm from tetramethylsilane with solvent as internal 
standard (deuterochloroform δ 77.0). Mass spectra were obtained on a VG-7070 or Fisons 
Autospec high resolution magnetic sector mass spectrometer. Analytical thin layer 
chromatography was performed as previously described on 230-240 mesh silica gel. [27] 
Analytical gas liquid chromatography was performed on a Varian 3900 gas chromatograph with 
a flame ionization detector and split mode capillary injection system, using ChiraldexTM –TA 
column (20 m x 0.25 m). Analytical high performance on a Hewlett Packard 1100 liquid liquid 
chromatograph equipped with a variable wavelength UV detector (deuterium lamp, 190-600 
nm), using Diacel ChiralcelTM OD-H column (250 x 4.6 mm). HPLC grade isopropanol and 
hexanes were used as eluting solvents. 
All experiments were carried out under a nitrogen atmosphere in oven or flame-dried 
glassware using standard inert atmosphere techniques for the manipulation of solvents and 
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reagents. Anhydrous solvents were obtained by passing through successive alumina columns on 
a solvent purification system.   
 
(S)-4-Methyl-oxetan-2-one (74) [28]: To a solution of 3.684 g of triamine ligand 
precursor to catalyst 63 (6.81 mmol) in 100 mL of CH2Cl2 was added 3.74 mL of  
trimethylaluminum (7.49 mmol) (2 M solution in hexanes) and was stirred for 2 h. 
The solution was cannulated into a solution of 36.0 g of tetraethylammonium bromide in 100 mL 
of CH2Cl2, cooled to –78 °C, and 20.2 mL of diisopropylethylamine (115.6 mmol) was added to 
it followed by the slow addition of 9.5 mL of acetylbromide (129.2 mmol). To the resulting pale 
yellow solution was added 4.2 mL of acetaldehyde (68.0 mmol).  The reaction mixture was 
stirred overnight at –78 °C, poured into 500 mL of cold hexanes and filtered through a short plug 
of silica gel with ether. The filtrate was concentrated to afford 5.2 g of lactone 61 (89%, crude) 
as a pale yellow oil. Separation of enantiomers by chiral GC [chiraldex G-TA column, flow rate 
0.6 mL/min, method: 80 °C for 5.0 min, ramp @ 5 °C /min to 100 °C for 10min, ramp @ 5 °C 
/min to 160 °C for 30 min. Tr 10.94min (R) and 11.84 min (S) determined enantiomeric excess to 
be 98.4%; 1H NMR (300 MHz, CDCl3): δ 4.73–4.67 (m, 1H), 3.58 (dd, J = 5.7, 16.2 Hz, 1H), 
3.06 (dd, J = 4.2, 16.3 Hz, 1H), 1.57 (d, J = 6.1 Hz, 3H).  
O
O
 
(S)-3-Hydroxy-N-methoxy-N-methyl-butyramide (74a) [28]: To a 0 °C 
solution of 11.8 g of N,O-dimethylhydroxylamine hydrochloride (12.0 
mmol) in 280 mL of CH2Cl2, was added 120 mL of 
dimethylaluminumchloride (1 M solution in hexanes) (0.12 mmol) and the resulting solution was 
allowed to stir at ambient temperature for 2 h. To the clear solution was added, a solution of 
MeN
O
Me
MeO
OH
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lactone 74 in 20 mL of CH2Cl2, slowly via syringe. The resulting pale yellow solution was stirred 
overnight and quenched with 360 mL of pH 8 phosphate buffer (3 mL/mmol of Me2AlCl). The 
organic layer was separated, filtered through celite, and the aqueous layer extracted with CH2Cl2 
(5 x 200 mL). The organics were combined, dried over Na2SO4 and concentrated. The crude 
product was purified by flash chromatography (10–40% EtOAc/Hex) to afford 6.26 g of the title 
compound (71%) as a pale yellow oil: [α]D = +48.0 (c 2.50, CHCl3) 1H NMR (300 MHz, 
CDCl3): δ 4.17 (ddq, J = 2.6, 6.4, 9.0 Hz, 1H), 3.68 (s, 3H), 3.18 (s, 3H), 2.65 (d, J = 16.4 Hz, 
1H), 2.43 (dd, J = 9.5, 16.8 Hz, 1H), 1.22 (d, J = 6.3 Hz, 3H). 
 
 
 (S)-(tert-Butyldimethylsilanyloxy)-N-methoxy-N-methylbutyramide 
(75): To a 0 °C solution of 3 g of Weinreb amide 74a (20.5 mmol) in 
CH2Cl2 (  mL), was added 3.58 mL (20.5 mmol) of diisopropylethylamine, 
followed by 0.50g (4.1 mmol) of dimethylaminopyridine (DMAP) and 5.26 g (35.0 mmol) of 
tert-butyldimethylchlorosilane. The reaction mixture was allowed to warm to ambient 
temperature and stirred for 24 h, and quenched with 20 mL of a saturated solution of NaHCO
41
3. It 
was extracted with CH2Cl2 (5 x 30 mL) and the combined organic layers washed with brine (25 
mL) and dried over Na2SO4. After concentrating the solution the crude product was purified by 
flash chromatography on silica gel (10% EtOAc in hexanes) to give  4.55 g (85%) of the title 
compound as a colorless oil: [α]D = +22 (c 1.2, CHCl3); IR (thin film): 2957, 2930, 2896, 2856, 
1655, 1472, 1386, 1255, 1135, 1004, 836 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.32 (app. sextet, 
J = 6.0 Hz, 1H), 2.73 (dd, J = 14.0, 7.2 Hz, 1H), 3.66 (s, 3H), 3.13 (s, 3H), 2.30 (dd, J = 14.5, 
5.4 Hz, 1H), 1.17 (d, J = 6.1 Hz, 3H), 0.83 (s, 9H), 0.05 (s, 3H), 0.03 (s, 3H); 13C NMR (75 
MeN
O
Me
MeO
OTBS
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MHz, CDCl3): δ 172.2, 66.0, 61.2, 41.6, 31.7, 25.7, 24.0, 18.0, –4.8, –5.0; EI-MS e/v 246 (M+–
Me), 204 (M+–tBu), 159, 129, 115; HRMS calcd for C11H24NO3Si: 246.1525, found 246.1515. 
 
 
(3S)-3-tert-Butyldimethylsilanyloxy)butyraldehyde (76): To a –78 °C solution 
l)
(4S,2′S)-4-[2-(tert-Butyldimethylsilanyloxy)propyl]-oxetan-2-one (72): To a 
Cl
of 0.500 g of Weinreb amide 75 (1.91 mmol) in 10 mL of CH2Cl2, was added 2.1 
 of diisobutylaluminumchloride (1.0 M solution in hexanes) slowly. The reaction 
was stirred for 45 min at –78 °C and quenched with 0.1 M HCl (5 mL). The layers were 
separated, the organic layer filtered through celite and the aqueous layer washed with CH
MeH
O OTBS
mL (2.1 mmo
2Cl2 (5 
x 20 mL). The combined organics were dried over Na2SO4, concentrated  and purified by flash 
chromatography on silica gel (2% EtOAc in hexanes) to afford 0.352 g  (91%) of aldehyde 76 as 
a colorless oil: [α]D = +16.1 (c 1.20, CHCl3); IR (thin film): 3002, 2957, 2930, 1724, 1265, 837, 
738 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.78 ( t, J = 2.1 Hz, 1H), 4.34 (app. sextet, J = 6.2 Hz, 
1H), 2.73 (ddd, J = 15.7, 6.9, 2.7 Hz, 1H), 2.30 (ddd, J = 15.6, 5.0, 1.8 Hz, 1H), 1.22 (d, J = 6.1 
Hz, 3H), 0.85 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 202.0, 64.5, 
53.0, 25.7, 24.1, 18.0, –4.4, –4.9; EI-MS e/v 145 (M+–tBu), 101 (M+–tBu–CH3CHO), 75; HRMS 
calcd for C6H12O2Si: 145.0685, found 145.0681. 
 
solution of 0.164 g of triamine ligand precursor to catalyst 63 (0.30 mmol) in 
5.8 mL of CH2 2 was added 0.166 mL of trimethylaluminum (0.33 mmol) (2 M solution in 
hexanes) and was stirred for 2 h. The solution was cooled to –50 °C, and 0.90 mL of 
diisopropylethylamine (5.2 mmol) was added to it followed by the slow addition of 0.42 mL of 
Me
O OTBS
O
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acetylbromide (5.7 mmol). To the resulting pale yellow solution was added 0.613 g of aldehyde 
76 (3.03 mmol) in 1.8 mL of CH2Cl2.  The reaction mixture was stirred overnight at –50 °C, 
poured into cold hexanes and filtered through a short plug of silica gel with 30% EtOAc in 
hexanes. The filtrate was concentrated and the crude product purified by medium pressure 
chromatography (0–10% EtOAc in hexanes) to afford 0.607 g of lactone 72 (82%) as a colorless 
oil:  [α]D = +8.3 (c 0.5, CHCl3); IR (thin film): 2956, 2930, 2887, 2857, 1831, 1124, 836 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 4.71–4.63 (m, 1H), 3.98 (app. sextet, J = 6.1 Hz, 1H), 3.53 (dd, J = 
16.3, 5.7 Hz, 1H), 3.14 (dd, J = 16.3, 4.3 Hz, 1H), 2.11 (ddd, J = 13.7, 6.4, 6.4 Hz, 1H), 1.80 
(ddd, J = 13.7, 7.1, 5.1 Hz, 1H), 1.20 (d, J = 6.2 Hz, 3H), 0.87 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H); 
13C NMR (75 MHz, CDCl3): δ 168.2, 68.7, 65.3, 43.6, 43.3, 25.7, 23.4, 17.9, –4.0, –4.5; EI-MS 
e/v 229 (M+–Me), 187 (M+–tBu), 145, 115, 101, 88; HRMS calcd for C8H15O3Si: 187.0790, 
found 187.0800. 
 
 (3R,5S)-5-(tert-Butyldimethylsilanyloxy)-3-methylhexanoic 
acid (71): T
m
   
o a –50 °C solution of 0.44 g of CuBr (3.1 mmol) in 20 mL of 
ethylsulfide, was added 2.1 mL of methylmagnesiumbromide (6.2 mmol)  
(3 M solution in ether) slowly to give a yellow suspension. The suspension was allowed to warm 
to –30 °C and stirred at that temperature for 30 min. The reaction mixture was cooled back to  
–50 °C, and 0.500 g of lactone 72 (2.05 mmol) in 5 mL of THF was added to it, and then it was 
maintained at –50 °C for 45 min. 0.39 mL (3.07 mmol) of trimethylsilylchloride was added to it 
and the reaction mixture was allowed to warm to ambient temperature. It was quenched with 20 
mL of 0.1 M HCl and solid NH
Me
MeO
HO
OTBS
THF and 5 mL of di
4Cl. After separation of the layers, the organic layer was washed 
with 10 mL of saturated NH4Cl solution and the aqueous layer extracted with ether (5 x 30 mL). 
 25 
The combined organics were dried over Na2SO4, concentrated and the crude product purified by 
flash chromatography (5% EtOAc in hexanes) to yield 0.378 g of carboxylic acid 71 as a pale 
yellow, viscous oil: [α]D = +23.4 (c 0.58, CHCl3); IR (thin film): 3583, 2958, 2929, 2857, 1709, 
1462, 1256, 1065, 835 cm-1; 1H NMR (300 MHz, CDCl3): δ 3.94–3.84 (m, 1H), 2.41–2.32 (m, 
1H), 2.22–2.14 (m, 2H), 1.52 (ddd, J = 13.5, 8.4, 4.5 Hz, 1H), 1.22 (ddd, J = 12.7, 8.3, 4.0 Hz, 
1H), 1.14 (d, J = 6.0 Hz, 3H), 0.98 (d, J = 6.3 Hz, 3H), 0.90 (s, 9H), 0.06 (s, 6H); 13C NMR (75 
MHz, CDCl3): δ 179.4, 66.3, 46.6, 42.3, 26.6, 25.8, 24.3, 19.6, 18.0, –4.1, –4.8; EI-MS e/v 245 
(M+–Me), 227 (M+–Me–H2O), 203 (M+–tBu), 185 (M+–tBu–H2O), 159, 143, 129, 111; HRMS 
calcd for C12H25O3Si: 245.1573, found 245.1565. 
 
(3R,5S)-5-(tert-Butyldimethylsilanyloxy)-3-methylhexanal (77): To a 
2
Me
MeO
H
OTBS
solution of 0.868 g of carboxylic acid 77 (3.38 mmol) in 16 mL of THF was 
.0 M solution of BHadded 2.5 mL of a 3.Me2S (5.0 mmol) in 16mL of THF. The solution was 
refluxed for 2 h, cooled and the solvent evaporated in vacuo. The residue was dissolved in 16 mL 
of CH2Cl2, and refluxed with 1.79 g of pyridinium chlorochromate (8.34 mmol) for 3 h. The 
reaction mixture was cooled, diluted with CH2Cl2, and filtered through a short plug of silica. The 
filtrate was concentrated, and the crude product purified by flash chromatography on silica gel 
(2% EtOAc in hexanes) to afford 0.684 g of aldehyde 77 as a colorless oil: [α]D = + 41.6 (c 0.85, 
CHCl3); IR (thin film): 2957, 2929, 2857, 2710, 1728, 1472, 1255, 1134, 1070, 836 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 9.73 (t, J = 2.4 Hz, 1H), 3.93–3.83 (m, 1H), 2.38 (ddd, J = 14.8, 
8.7, 2.5 Hz, 1H), 2.33–2.19 (m, 2H), 1.48 (ddd, J = 14.8, 8.8, 4.1 Hz, 1H), 1.25–1.17 (m, 1H), 
1.13 (d, J = 6.0, 3H), 0.96 (d, J = 6.2, 3H), 0.88 (s, 9H), 0.06 (s, 6H); 13C NMR (75 MHz, 
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CDCl3): δ 202.9, 66.1, 51.6, 46.8, 25.8, 24.8, 24.4, 19.7, 18.0, –4.1, –4.8; EI-MS e/v 243 (M+–
H), 187 (M+–tBu), 159, 145, 115; HRMS calcd for C13H27O2Si: 243.1780, found 243.1783.  
 
   (5R,7S)-7-(tert-Butyldimethylsilanyloxy)-5-methyl-oct-
2-enoic acid ethyl ester (77a): To a 0 °C suspension of 0.15g of 
NaH (3.95 mmol) in THF (14 mL), was added 0.86 mL of diisopropyl(ethoxycarbonylmethyl) 
phosphonate (3.59 mmol). This was stirred at 0 °C for 20 min and 0.624 g of aldehyde 77 
dissolved in THF (4 mL) was added to it. The reaction mixture was allowed to warm to ambient 
temperature, and then, 5 mL H2O was added, the layers separated and the aqueous layer washed 
with EtOAc (3 x 10 mL). The organics were combined and concentrated and the crude material 
was purified by flash chromatography (2% EtOAc in hexanes) to yield 0.645 g (80%) of ester 
77a as a yellow oil: [α]D = +12.9 (c 0.50, CHCl3); IR (thin film): 3020, 2958, 2929, 2857, 1712, 
1653, 1463, 1256, 1215, 836, 757 cm-1; 1H NMR (300 MHz, CDCl3): δ 6.93 (ddd, J = 15.3, 7.4, 
7.4 Hz, 1H), 5.82 (dd, J = 15.5, 1.4, 1.4 Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 3.90–3.86 (m, 1H), 
2.19 (dddd, J = 13.0, 7.3, 7.3, 1.3 Hz, 1H), 2.03 (dddd, J = 14.0, 7.4, 7.4, 1.3 Hz, 1H), 1.80–1.90 
(m, 1H), 1.50 (ddd, J = 13.4, 8.8, 4.4 Hz, 1H), 1.29 (t, J =7.1 Hz, 3H), 1.12 (d, J = 6.0 Hz, 3H), 
1.17–1.08 (m, 1H), 0.89 (d, J = 6.8 Hz, 3H), 0.88 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H); 13C NMR 
(75 MHz, CDCl3): δ 166.7, 148.0, 122.5, 66.3, 60.1, 46.8, 40.3, 28.8, 26.0, 24.5, 19.5, 18.1, 14.3, 
–3.9, –4.7; EI-MS e/v 257 (M+–tBu), 228 (M+–tBu–C2H4), 211, 159, 149, 115, 109, 95; HRMS 
calcd for C13H25O3Si: 257.1572, found 257.1568. 
Me
Me OTBS
EtO
O
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 (5R,7S)-5-Methyl-oct-2-ene-1, 7-diol (70):  To a solution of 
0.402 g of ester 77a (1.3 mmol) in CH2Cl2 (10 mL) at ambient 
temperature, was added 6.4 mL of diisobutylaluminumchloride (6.4 mmol) (1 M in hexanes), 
and stirred for 2 h. The reaction mixture was quenched with 0.1 M HCl, extracted with CH2Cl2 
(3 x 20 mL) and the organic layer filtered through celite. After evaporation of solvents in vacuo, 
the crude product was purified by chromatography on silica (20–40% EtOAc in hexanes) to yield 
0.200 g (77%) of  diol 70  as a colorless oil: [α]D = +22.5 (c 0.45, CHCl3); IR (thin film): 3334, 
963, 2920, 1459, 1376, 1127, 1085, 1003, 970 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.66–5.51 
(m, 2H), 4.00 (br s, 2H), 3.84–3.77 (m, 1H), 3.22 (br s, 1H), 2.74 (br s, 1H), 1.92 (dd, J = 6.4, 
6.4 Hz, 2H), 1.72–1.61 (m, 1H), 1.48 (ddd, J = 13.6, 8.9, 4.4 Hz, 1H), 1.12 (d, J = 6.1 Hz, 3H), 
1.05 (ddd, J = 13.6, 9.3, 4.0 Hz, 1H), 0.86 (d, J = 6.6, 3H); 13C NMR (75 MHz, CDCl3): δ 131.0, 
130.8, 65.5. 63.1, 45.8, 40.1, 29.5, 24.2, 19.5; EI-MS e/v 140 (M+–H2O), 122 (M+–2H2O), 107, 
93; HRMS calcd for C9H16O: 140.1201, found 140.1198. 
Me
Me OH
HO
 
 (4R,2S)-4-Methyl-8-isopropylsilanyloxy-oct-6-en-2-ol 
(70a): To a 0 °C solution of 0.230 g of diol 70 (1.46 mmol) in 
CH2Cl2 (10 mL), was added 0.2 mL of triethylamine (1.46 mmol), followed by 0.1 g of 
imidazole (1.46 mmol) and 0.34 mL (1.46 mmol) of triisopropylchlorosilane. The reaction 
mixture was stirred for 2 h, and quenched with 5 mL of a saturated solution of NaHCO3. It was 
extracted with CH2Cl2 (3 x 10 mL) and the combined organic layers washed with brine (5 mL) 
and dried over MgSO4. After concentrating the solution, the crude product was purified by flash 
chromatography on silica gel (5–10% EtOAc in hexanes) to give  0.390 g (85%) of alcohol 70a 
as a colorless oil; [α]D = +8.2 (c 1.0, CHCl3); IR (thin film): 3356, 2960, 2943, 1463, 1377, 1104, 
Me
Me OH
TIPSO
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1055, 882, 680 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.71–5.51 (m, 2H), 4.21 (dd, J = 4.7, 1.1 
Hz, 2H), 3.95–3.85 (m, 1H), 2.07 (ddd, J = 13.6, 6.8, 6.8 Hz, 1H), 1.93 (ddd, J = 14.0, 7.0, 7.0 
Hz, 1H), 1.77–1.68 (m, 1H), 1.50 (ddd, J = 13.8, 9.4, 4.6 Hz, 1H), 1.27–1.15 (m, 1H), 1.19 (d, J 
= 6.2 Hz, 3H), 1.10–1.05 (m, 21H), 0.91 (d, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 
131.0, 129.8, 65.8, 64.0, 46.3, 40.3, 29.6, 24.4, 19.3, 18.0 12.0; EI-MS e/v 271 (M+–iPr), 187, 
141, 131, 123; HRMS calcd for C15H31O2Si: 271.2093, found 271.2093.   
 
 (4R)-4-Methyl-8-triisopropylsilanyloxy-oct-6-en-2-one 
(78): To a solution of 0.380 g (1.23 mmol) of alcohol 70a in 
CH2Cl2  (10 mL), was added 0.313 g of pyridiniumchlorochromate (1.45 mmol) at ambient 
temperature, and the reaction refluxed for 3 h. The reaction mixture was diluted with CH2Cl2 and 
filtered through a short plug of silica gel. The filtrate was concentrated and purified by flash 
chromatography (5% EtOAc in hexanes) to afford 0.355 g (94%) of ketone 78 as a colorless oil 
[α]D = +6.2 (c 1.2, CHCl3); IR (thin film): 2943, 2891, 2866, 1717, 1463, 1366, 1128, 1102, 972, 
882 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.65–5.48 (m, 2H), 4.17 (d, J = 4.0 Hz, 2H), 2.45 (dd, 
J = 15.7, 4.8 Hz, 1H), 2.20–1.90 (m, 4H), 2.08 (s, 3H), 1.06–1.00 (m, 21H), 0.87 (d, J = 6.3 Hz, 
3H); 13C NMR (75 MHz, CDCl3): δ 208.6, 131.4, 128.0, 63.6, 50.1, 39.3, 30.3, 29.1, 19.6, 17.9, 
11.9; EI-MS e/v 297 (M+–CH3), 269 (M+–iPr), 239 (M+–iPr –2CH3), 213, 171, 131; HRMS calcd 
for C15H29O2Si: 269.1936, found 269.1934.   
Me
Me O
TIPSO
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 (3R)-Trifluoromethanesulfonic acid 3-methyl-1-
methylene-7-triisopropylsilanyloxyhept-5-enyl ester (67): To 
a –78 °C solution of 1.43 mL of a 0.5 M solution of potassium bis(trimethylsilyl)amide in 
toluene (0.71 mmol) in THF (8 mL) was added a solution of 0.149 g of ketone 78 in THF (2 
mL), dropwise via syringe. The resulting solution was stirred at –78 °C for 15 min, and then a 
solution of 0.188 g (0.53 mmol) of N-phenyltriflimide in THF (2 mL) was cannulated into the 
reaction mixture which was then allowed to warm to 0 °C. 5 mL of a saturated NaHCO3 solution 
was added to it, the layers were separated, and the aqueous layer washed with ether (2 x 5 mL). 
The combined organics were dried over Na2SO4, concentrated and purified by column 
chromatography over silica gel (0.5% CH2Cl2 in hexanes, 2% Et3N) to afford 0.161 g (76%) of 
the title compound as a colorless oil; [α]D = –3.5 (c 1.0, CHCl3); IR (thin film): 2943, 2866, 
1463, 1419, 1211, 1141, 937, 883 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.70–5.54 (m, 2H), 5.14 
(d, J = 3.4 Hz, 1H), 4.92 (d, J = 3.4 Hz, 1H), 4.23–4.20 (m, 2H), 2.38 (dd, J = 15.8, 5.9 Hz, 1H), 
2.16–1.83 (m, 4H), 1.14–1.04 (m, 21H), 0.96 (d, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 
155.8, 132.0, 127.2, 118.6 ( JC-F = 318 Hz), 105.4, 63.7, 40.7, 38.7, 30.3, 18.8, 18.0, 12.0; EI-MS 
e/v 401 (M+–iPr), 251 (M+–iPr–CF3SO3H), 209, 157, 131, 121; HRMS calcd for C16H28O4F3: 
401.1429, found 401.1442.   
Me OSO2CF3
TIPSO
 
PTS
Me
CO tBu2 (E)-tert-Butyl-6-(1-phenyl-1H-tetrazol-5-ylthio)-2-
methylhex-2-enoate (80a): To a 0 °C solution of 0.500 g of alcohol 80 (2.5 mmol) and 0.890 g 
of N-phenyltetrazolethiol (5.9 mmol, 2.0 equiv) in 12.5 mL of DMF added 1.314 g of 
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triphenylphosphine (5.0 mmol, 2.0 equiv) and 1mL of DIAD (5.0 mmol, 2.0 equiv). The 
resulting yellow solution was warmed to ambient temperature and stirred overnight. The reaction 
mixture was quenched with brine (10 mL) and diluted with ether. After separation of layers, the 
aqueous layer was extracted with EtOAc (3 x 10 mL). The combined organics were dried over 
MgSO4 and the solvent was removed in vacuo. The crude product was purified by flash 
chromatography (10% EtOAc in hexanes) to afford 0.880 g of the title compound (98%) as a 
colorless oil: IR (thin film): 2977, 2931, 1703, 1649, 1500, 1388, 1254, 1157, 761 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 7.58–7.55 (m, 5H), 6.17 (br t, J = 6.2 Hz, 1H), 3.41 (t, J = 7.4 Hz, 2H), 
2.32 (dt, J = 7.4, 7.4 Hz, 2H), 2.00 (tt, J = 7.4, 7.4 Hz, 2H), 1.78 (s, 3H), 1.48 (s, 9H);   13C NMR 
(75 MHz, CDCl3): δ 167.2, 154.1, 138.6, 133.6, 130.5, 130.1, 129.8, 123.8, 80.2, 32.7, 28.0, 
27.4, 21.3, 12.5; HRMS calcd for C18H24N4O2S: 380.1619, found 380.1603. 
 
PTO2S CO2tBu
Me
 (E)-tert-Butyl-6-(1-phenyl-1H-tetrazol-5-ylsulfonyl)-2-       
methylhex-2-enoate (80b): To a solution of 0.660 g of ammonium molybdate (5.32 mmol, 20 
mol %) in 2 mL of EtOH added 3.0 mL of a 30% solution of hydrogen peroxide to produce a 
yellow solution. This was added to a solution of 0.960 g of sulfide 80a (2.66 mmol) in 10 mL of 
EtOH. The reaction mixture was stirred overnight and then was diluted with 50 mL of ether and 
20 mL of brine was added to it. After separation of the layers, the aqueous layer was extracted 
with EtOAc (3 x 30 mL). The combined organics were dried over MgSO4 and then the solvents 
were evaporated in vacuo to yield 0.900 g of the title compound (86%) as a white solid: m.p:    
94–96 °C; IR (thin film): 3068, 2978, 2933, 1704, 1650, 1498, 1366, 1228, 1155, 1080, 763    
cm-1; 1H NMR (300 MHz, CDCl3): δ 7.66–7.61 (m, 2H), 7.60–7.56 (m, 3H) 6.56 (br t, J = 7.4 
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Hz, 1H), 3.72 (br t, J = 7.7 Hz, 2H), 2.35 (dt, J = 7.3, 7.3 Hz, 2H), 2.07 (tt, J = 7.4, 7.4 Hz, 2H), 
1.77 (s, 3H), 1.46 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 166.9, 153.4, 137.1, 133.0, 131.5, 
131.4, 129.7, 125.1, 80.3, 55.3, 28.0, 26.8, 21.3, 12.5; HRMS calcd for C18H24N4O4S: 392.1518, 
found 392.1515. 
 
PTO S2
Me
CO H2  (E)-6-(1-Phenyl-1H-tetrazol-5-ylsulfonyl)-2-methylhex-2-enoic 
acid (80c): To a 0 °C solution of 0.620 g ester 80b (1.58 mmol) in 12 mL of a 5:1 mixture of 
CH2Cl2: anisole, added 2.7 mL of TFA (23.0 mmol, 15.0 equiv) dropwise via a syringe. After 
stirring at 0 °C for 1 h the solvents were evaporated in vacuo  to give a light brown solid which 
was recrystallized from CH2Cl2 in hexanes to yield 0.480 g of carboxylic acid  80c (90%) as a 
white solid: m.p: 118–119 °C; IR (thin film): 2931, 2665, 1682, 1643, 1498, 1318, 1300, 1151, 
764 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.72–7.69 (m, 2H), 7.66–7.61 (m, 3H), 6.83 (tq, J = 
7.3, 1.3 Hz, 1H), 3.77 (br t, J = 7.7 Hz, 2H), 2.47 (dt, J = 7.3, 7.3 Hz, 2H), 2.19 (tt, J = 7.6, 7.6 
Hz, 2H), 1.88 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 172.5, 153.4, 141.0, 132.9, 131.5, 129.7, 
129.4, 125.0, 55.3, 27.1, 21.2, 12.2; HRMS calcd for C14H16N4O4S: 336.0892, found 336.0871. 
 
 (E)-2-(trimethylsilyl) ethyl 6-(1-phenyl-1H-tetrazol-5-
ylsulfonyl)-2-methylhex-2-enoate (65): To a solution of 0.200 g 
of carboxylic acid  80c (0.59 mmol) and 0.26 mL of trimethylsilylethanol (1.78 mmol, 3.0 equiv) 
in 8 mL of THF, added 0.25 g of DCC (1.2 mmol, 2.0 equiv) and 0.073 g of DMAP (0.59 mmol, 
1.0 equiv). The resulting solution was stirred at ambient temperature for 3 d and worked up by 
PTO2S
Me
O
OTMSE
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the addition of 5 mL of brine and 25 mL of ether. After separation of layers the aqueous layer 
was extracted with ether (3 x 10 mL). The combined organics were dried over MgSO4 and the 
solvent was removed in vacuo. The crude product was purified by flash chromatography (10–
30% EtOAc in hexanes) to afford 0.220 g of the title compound as a colorless oil: IR (thin film): 
2953, 1706, 1650, 1498, 1340, 1251, 1153, 859 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.68–7.54 
(m, 5H), 6.65 (br t, J = 7.3 Hz, 1H), 4.22 (br t, J = 8.3 Hz, 2H), 3.73 (br t, J = 9.6 Hz, 2H), 2.39 
(dt, J = 7.3, 7.3 Hz, 2H), 2.11 (tt, J = 7.5, 7.5 Hz, 2H), 1.83 (s, 3H), 1.00 (br t, J = 8.8 Hz, 2H), 
0.03 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 167.6, 153.2, 137.9, 132.8, 131.4, 130.2, 129.6, 
124.9, 62.8, 55.2, 26.7, 21.1, 17.2, 12.5, –1.5; HRMS calcd for (M++Na) C19H28N4O4SiSNa: 
459.1498, found 459.1497. 
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2.0  THE DIENE PROBLEM: SOLUTION IN A MODEL SYSTEM 
2.1 INTRODUCTION 
We recognized that synthesis of the C13–C15 portion of amphidinolide B (1) containing a 
1, 3- exocyclic diene unit was potentially a challenging task, considering that there was no 
efficient way of making it in the literature. In Pattenden’s attempt at making 1, he disclosed that 
a final macrolactonization step involving an intramolecular copper-mediated Stille reaction was 
unsuccesful. [12] The presence of a trisusbtituted alkene at C14–C15 makes a sterically congested 
reaction partner in any coupling reaction to form the C13–C14 bond. Since this was a relatively 
unexplored area in the synthesis of 1, we decided to take up the task of forming the C13–C15 
diene in an efficacious manner. 
2.2 INSTALLATION OF THE C16- AND C18- STEREOCENTERS 
2.2.1 Retrosynthetic analysis of fragment 68 
We envisioned the formation of the C18- stereocenter strategically via an asymmetric 
AAC reaction. Thus, β-ketophosphonate 68 would be formed via a phosphonate anion opening 
of β-lactone 81 (Figure 14). An AAC reaction would be used to form the enantioenriched β-
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lactone 81 from aldehyde 82. The C16- tertiary alcohol would be formed via a Sharpless 
asymmetric epoxidation of allylic alcohol 83.   
 
MeTBSO OTBS
P(OEt)2
O O
TMS 68
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TMS
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TMS
H
TBSO Me O
TMS
Me
OH
81
8283  
 
Figure 14: Retrosynthetic analysis of fragment 68 
 
The synthesis of aldehyde 82 closely resembled a strategy that Pattenden used for a 
similar substrate in his partial synthesis [11] (Scheme 3). It commenced with the Sharpless 
epoxidation [29] of known allylic alcohol 83 [30] to afford epoxide 84 in 83% yield and 88% ee. 
Hydride-mediated opening of epoxide 84 with lithium aluminum hydride gave diol 85 in 56% 
yield. A three step sequence of protection of the diol, selective removal of the primary silyl 
group followed by Dess-Martin oxidation [31] afforded aldehyde 82 in an overall yield of 64%. 
Aldehyde 82 was then subjected to an AAC reaction with acetyl bromide in the presence of 
Al(III) triamine catalyst 63 to give 1, 3-syn β-lactone 81 in 88% yield and 95% de, thus correctly 
setting the C18 stereocenter. [26] 
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Scheme 3: Installation of the C16- and C18- stereocentersa 
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aCondtions: (a) 30 mol %  Ti(OiPr)4, (+)-DIPT, tBuOOH, CH2Cl2. (b) LiAlH4, Et2O, 0 °C.
(c) TBSOTf, 2,6-lutidine, 0 C-RT. (d) DDQ, THF-H2O. (e) Dess-Martin periodinane, CH2Cl2.
(f) 10 mol % 63, MeCOBr, iPr2NEt, –50 °C.
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2.3 INSTALLATION OF THE C14–C15 TRISUBSTITUTED ALKENE 
With β-lactone 81 in hand, we decided to elaborate it into a suitable compound that 
would enable studies toward the formation of the C14–C15 trisubstituted alkene as well as the 
diene unit in 1 (Scheme 4). Amine-mediated ring-opening of 81 afforded Weinreb amide 86 in 
91% yield in which the free hydroxyl group was protected as the tert-butyldimethylsilyl ether 
and the alkynyl silyl group was selectively cleaved with KOH/MeOH in an overall 88% yield. 
Terminal alkyne 87 thus contained the requisite functionality for further manipulation along the 
C14–C15 bond. 
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 Scheme 4: Synthesis of alkyne substrate for carbometalation studiesa 
 
O
O
TMS
TBSO Me OH
TMS
TBSO Me O
N
Me
OMe
OTBSTBSO Me O
N
Me
OMe
a
b, c
aConditions: (a) MeNH(OMe).HCl, Me2AlCl. (b)TBSOTf, 2,6-
lutidine. (c) KOH, MeOH.
91%
88%
81 86
87
 
 
In order to carbometalate terminal alkyne 87, we investigated the stannylcupration 
reaction discovered by Lipshutz in the late 1980’s. [32] Although this is a synthetically very 
useful route to vinylstannanes, evidence in the literature suggests that the regioselectivity of 
stannylcupration of terminal alkynes is variable under kinetic and thermodynamic control. [33] 
In order to carbostannylate a terminal alkyne, the intermediate vinyl cuprate species has to be 
quenched with an electrophilic alkylating agent. Such reactions have literature precedent, [34] 
although to the best of our knowledge, not with an alkyne bearing a neopentyl substituent.  
 
Higher order stannylcuprate reagents were prepared following Oehlschlager’s procedure, 
[33]33 and alkyne 87 was treated with them at –50 °C (Scheme 5). The intermediate vinyl 
cuprates 87a were quenched with excess methyliodide at –50 °C to afford vinyltributylstannane 
88 and vinyltrimethylstannane 89. The use of alkyltributylstannyl cuprate gave a better yield of 
88 (83%) compared to the bis(stannyl)cuprate (64%). Carbostannylation with 
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trimethylstannylcuprate was found to be less efficient than tributylstannylcuprate in terms of 
reactivity with alkyne 87. However, use of the more reactive mixed 
alkyl(trimethylstannyl)cuprate reagent in excess afforded trimethylstannane 89 in 64% yield. 
Proof of regiochemistry of carbostannylation was obtained by conversion of stannane 88 to vinyl 
iodide 90 with molecular iodine (98%) and subsequent DEPT and nOe studies. 
 
Scheme 5: Carbostannylation studies on alkyne 87a
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aConditions: (a) i. Cuprate, –50 °C, THF; ii. excess MeI, –50 °C–RT. (b) I2, CH2Cl2.
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2.4 STILLE COUPLING STUDIES 
2.4.1 Standard conditions 
 Having shown that we could synthesize the requisite trisubstituted vinylstannane 
in the model “upper fragment” 87, we wanted to explore its ability to engage in a Stille coupling 
reaction with triflate 67 to form the C13–C14 bond in amphidinolide B. Stannane 88 and triflate 67 
were subjected to the original Stille reaction conditions developed by Scott and Stille, with 15 
mol% loading of palladium, triphenylphosphine as the ligand and lithium chloride as an additive. 
[35] However, no desired product was observed (Eq 2) indicating that modified reaction 
conditions would have to be applied.  
 
 
(2) 
TBSO Me OTBS
N
O
OMe
Me
Me
nBu3Sn
+
Pd2(dba)3, PPh3
LiCl, THF, reflux
Me
OTf
OTIPS
88
67
TBSO Me OTBS
N
O
OMe
Me
Me
Me
OTIPS
91
 
  
 
 
2.4.2 Coupling under modified Stille conditions 
 As the next trial of forming the C13–C15 diene in a model system, the Corey- 
modified protocol of the Stille reaction that was originally developed for sterically congested  
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1-substituted vinylstannanes, was investigated. [36] In order to serve preliminary coupling 
studies, known triflate 92 derived from phenol was prepared (Scheme 6). [37] Both stannanes 88 
and 89 were subjected to cuprous chloride-accelerated Stille reactions with triflate 92. The 
reaction of tributylstannane 88 yielded 30% of recovered stannane 88 along with 7% of 
homocoupled product 93 of the vinyl stannane and some unidentifiable material. 
Trimethylstannane 89 proved to be better in terms of reactivity in that all the starting material 
stannane was consumed to afford 19% yield of the desired coupled product 94 as well as 20% of 
homocoupled product 93.  
 
Scheme 6: The Corey-modified Stille trials on model system 
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Homocoupling of vinylstannanes in the presence of cuprous chloride has precedent in the 
literature. [38] Identifying reaction conditions that would retain the reactivity of the stannane and 
at the same time prevent self-coupling was important for the success of our Stille reaction. 
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Hence, we decided to test the Farina-modified Stille coupling strategy of using triphenylarsine 
ligands that tend to dissociate more readily from the palladium during the course of the reaction. 
[39] When vinylstannane 88 was reacted with model triflate 92 in the presence of 10 mol% 
Pd2(dba)3 and 40 mol% Ph3As with lithium chloride as an additive in N-methylpyrrolidinone 
(NMP), the desired product 94 was formed in 21% yield, and starting material stannane 88 was 
recovered in 20% yield along with other unidentified material (Scheme 7). We were, however, 
pleased to find that trimethylstannane 89 underwent the reaction, under the same conditions, to 
completion to afford desired product 94 in 60% yield.  
 
Scheme 7: The Farina-modified Stille reaction trials on model system 
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Application of these successful conditions to triflate 67 was our next priority. 
Disappointingly, under identical conditions, when stannane 89 was reacted with triflate 67 the 
only product recovered was destannylated compound 95 (Eq 3).  
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(3) 
 
 
 
2.4.3 Summary of Stille coupling studies 
Table 2 summarizes the trials performed to study the coupling of stannanes 88 and 89 
with phenyl trifluoromethanesulfonate 92 and triflate 67 under various modified Stille 
conditions. 
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Table 2: Modified Stille coupling studies 
stannane                    triflate                   conditions                           result
employed                    partner
88 PhOTf Pd(PPh3)4,
CuCl, LiCl,
DMSO, 60° C
88     +   
30%
dimer   
  7%
89 PhOTf
Pd(PPh3)4,
CuCl, LiCl,
DMSO, 60° C
coupled product  +
   19%
dimer 
   20%
88 PhOTf Pd2(dba)3
Ph3As, LiCl,
NMP, 65° C
coupled  +   
product 
   21%
88    
 20%
89 PhOTf Pd2(dba)3Ph3As, LiCl,
NMP, 65° C
coupled    
product 
   60%
89 67 Pd2(dba)3
Ph3As, LiCl,
NMP, 65° C
destannylated 
product 95
    68%
 
2.5 SUZUKI COUPLING STUDIES 
2.5.1 Attempted transmetalation of vinyl iodide fragment 90 
Our first strategy in investigating the Suzuki coupling strategy was to convert iodide 90 
into a boronic acid/ester that could potentially couple with the same triflate fragment 67. 
Although we could effect the formation of vinyllithium 90a from iodide 90, we were unable to 
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transmetalate the intermediate vinyllithium species with trialkoxyborates (Scheme 8). This result 
prompted us to explore other avenues to investigate the Suzuki coupling strategy. 
 
Scheme 8: Attempted conversion of iodide 90 to boronic acid  
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2.5.2 Attempted modification of triflate fragment 67 
The next step towards making substrates suitable for testing the Suzuki coupling strategy 
was to modify triflate fragment 67 suitably so that it could function as the transmetalating partner 
instead of undergoing oxidative addition during the coupling reaction. Since iodide 90 was 
available directly from stannane 88, it could be used as the electrophile undergoing oxidative 
addition onto palladium in the cross-coupling reaction.  
 
We decided to apply Miyaura’s one-pot procedure of converting a vinyl triflate into a 
vinyl boronic ester using (bispinacolato)diboron and dichlorobis(triphenylphosphine) palladium 
as a catalyst and potassium phenoxide as a base. [40] Disappointingly, we observed no desired 
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product from this reaction (Eq 3). Although we do not have adequate proof of this hypothesis, we 
speculated that a reason for this could be a competing intramolecular Heck-type reaction that 
could occur in a 5-exo-dig manner after oxidative addition of triflate 67 on catalytic 
palladium(0). This was perceived as a counter-productive pathway in the previously performed 
Stille reaction studies, and could well be the reason that no desired coupled product was 
observed in the trials employing triflate 67 as the electrophilic partner. 
 
 
                     (3) 
 
 
2.5.3 Synthesis of model boronic acid/ester compounds  
In order to expedite our studies on the formation of the C13–C14 linkage in amphidinolide 
B, we decided to synthesize a model boronic ester that would closely resemble fragment 67. A 
rapid synthesis of triflate 96 from commercially available S-(–)-citronellal was then initiated 
(Scheme 9). Thus, kinetic enolization of the methyl ketone derived from S-(–)-citronellal [41] 
and trapping with N-phenyl triflimide gave triflate 96 which then smoothly underwent 
transformation to boronic ester 97 following Miyaura’s protocol in 70% yield. 
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Scheme 9: Synthesis of model boronate ester from S-(-)-citronellala 
 
HO
Me
OTf
Me
a, b
53%
aConditions: (a) i. MeMgBr, THF; ii. PCC, CH2Cl2, reflux. (b) KHMDS, PhNTf2, THF, -78 °C. 
(c) B(pin)-B(pin), 10 mol % Pd(PPh3)2Cl2.2PPh3, PhOK, toluene, 50 °C.
Bpin
Me
c
70%
96 97
 
 
Since it proved difficult to hydrolyze boronate ester 97 into the corresponding boronic 
acid in the presence of the isolated double bond in it, [42] we sought to prepare boronic acid 98 
from triflate 96. Conversion of triflate 96 to iodide 99 proceeded in two steps through an 
intermediate trimethylstannane (61%). Transmetalation of iodide 99 with butyllithium, 
quenching the intermediate vinyllithium with trimethylborate and acidic workup produced 
boronic acid 98 (Scheme 10). 
 
Scheme 10: Synthesis of model boronic acid from S-(-)-citronellala 
OTf
Me
I
Me
B(OH)2
Me
a, b c
aConditions: (a) (Me3Sn)2, 10 mol % Pd(PPh3)4 LiCl, THF, 60 °C. (b) I2, CH2Cl2. 
(c) BuLi, B(OMe)3, THF, -78 °C–RT.
61% 74%
96 99 98
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2.5.4 Suzuki trials in the model system 
With model boronate fragments 97 and 98 in hand, we investigated their ability to 
participate in Suzuki reactions with iodide 90 (Eq 4). Under standard Suzuki reaction conditions 
at 45 °C, employing (dppf)PdCl2 as the catalyst and DMF as the solvent, it was found that 
boronic acid 98 was much inferior to boronate ester 97 in terms of conversion to product diene 
100. Reaction times and thus integrity of the diene were strongly dependent on the nature of the 
base additive. Thus, when bases such as potassium hydroxide, cesium carbonate or potassium 
carbonate were used, prolonged reaction times were observed, and in most cases, isomerized 
diene 101 was detected. However, reaction of boronate ester 98 when barium hydroxide was 
used as the base afforded diene 100 in 64% yield as the sole product uncontaminated with 
isomerized diene 101. 
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MeTBSO OTBSO
N
Me
OMeMe
Me
Me
B(OR)2
MeTBSO OTBSO
N
Me
OMeMe
I
30 mol%Pd(dppf)Cl2
3.0 equiv Ba(OH)2
DMF, 45 οC
(4)
MeTBSO OTBSO
N
Me
OMeMe
Me +
coupling partner        base           reaction time            conversion       ratio of dienes
(98/97)(OR)2 =                                  (h)                                                (100 : 101)
(OH)2 KOH 20 33 100:0
(OH)2 Cs2CO3 20  50 0:100
pin K3PO4 20 100 40:60
pin Cs2CO3 20 100 0:100
pin Ba(OH)2 3 100 100:0
101100
90
97/98
(OH)2 K3PO4 20  50 10:90
 
 
2.6 SUMMARY 
Catalytic asymmetric methodologies were successfully applied to construct the C16- and 
C18- stereocenters in amphidinolide B. The Stille and Suzuki cross-coupling methods were 
investigated for the formation of the C13–C15 diene. Optimized reaction conditions for connecting 
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two major fragments of amphidinolide B using the Suzuki coupling strategy were found in a 
suitable model system.  
 
EXPERIMENTAL SECTION 
 
[(2S,3S)-3-methyl-3-(2-(trimethylsilyl)ethynyl)oxiran-2-yl]methanol 
(84): To a –20 °C suspension of 0.62 g of 4Å molecular sieves in 11 mL 
of CH2Cl2 was added a solution of 0.62 g of (+)-DIPT (2.64 mmol, 0.36 equiv) in 3 mL of 
CH2Cl2 followed by 0.65 mL of titanium isopropoxide (2.2 mmol, 0.3 equiv), and 2.67 mL of 
tert-butylhydroperoxide (5.5 M solution in decane, 14.7 mmol, 2.0 equiv). The resulting solution 
was stirred for 30 min at –20 °C and then a solution of 1.15 g of allylic alcohol 83 (7.35 mmol) 
in 5 mL of CH2Cl2 was added to it. The reaction mixture was stirred at the same temperature for 
5 h and quenched with a freshly prepared solution of 0.57 g of ferrous sulfate and 0.17 g of citric 
acid in water (10 mL). The organic layer was separated from the aqueous layer and filtered 
through a short plug of florisil and the filter cake was washed with 20% solution of EtOAc in 
hexanes. The aqueous layer was extracted with CH2Cl2 (5 x 30 mL) and the combined organics 
were dried over Na2SO4 and the solvents were evaporated in vacuo. The crude product was 
purified by medium pressure chromatography (10–30% EtOAc in hexanes) to afford 1.04 g of 
epoxide 84 (83%) as a colorless oil. Mosher ester analysis of the purified epoxide determined the 
enantiomeric excess to be 88%: [α]D =  –0.62 (c 1.80, CHCl3); IR (thin film): 3431, 2960, 2167, 
1642, 1250, 1032, 842 cm-1; 1H NMR (300 MHz, CDCl3): δ 3.84 (dd, J = 12.4, 4.4 Hz, 1H), 3.68 
TMS
Me
O
OH
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(dd J = 12.3, 6.2 Hz, 1H), 3.37 (dd, J = 6.0, 4.6 Hz, 1H), 2.04 (br s, 1H), 1.53 (s, 3H), 0.16 (s, 
9H); 13C NMR (75 MHz, CDCl3): δ 105.1, 87.4, 64.3, 60.5, 51.4, 18.6, –0.2; HRMS calcd for 
C8H13O2Si:  169.0685 found 169.0686. 
 
(R)-3-methyl-5-(trimethylsilyl)pent-4-yne-1,3-diol (85): To a 0 °C 
solution of epoxide 84 (4.90 mmol) in 30 mL of ether added 4.9 mL of 
lithium aluminum hydride (1 M solution in hexanes, 4.90 mmol) dropwise via syringe. Stirred 
for 15 min at 0 °C and then quenched with 10 mL of 0.2 M aqueous hydrochloric acid solution. 
After the layers were separated, the aqueous layer was extracted with ether (5 x 40 mL). The 
combined organics were washed with 5 mL of brine and dried over Na2SO4. The solvent was 
evaporated in vacuo and the crude product was purified by medium pressure chromatography 
(10–35% EtOAc in hexanes to afford 0.510 g of the title compound (56%, 60% brsm) as a 
colorless oil: [α]D =  +24.2 (c 2.10, CHCl3); IR (thin film): 3367, 2959, 2165, 1409, 1250, 932 
cm-1; 1H NMR (300 MHz, CDCl3): δ 4.19 (s, 1H), 4.10–4.03 (m, 1H), 3.87–3.82 (m, 1H), 3.43 
(br s, 1H), 1.91 (ddd, J = 14.3, 9.3, 4.2 Hz, 1H), 1.77 (ddd, J = 14.4, 4.8, 3.6 Hz, 1H), 1.47 (s, 
3H), 0.12 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 108.8, 87.7, 68.8, 60.3, 43.6, 30.5, 0.0; HRMS 
calcd for C8H15O2Si:  171.0841 found 171.0840. 
TMS
OH
MeHO
 
(R)-3,5-Bis-(tert-butyldimethylsilanyloxy)-3-methyl-1-
trimethylsilanylpent-1-yne (85a): To a 0 °C solution of 0.680 g of 
diol 85 (3.65 mmol) in 18 mL of CH2Cl2 added 2.1 mL of 2,6-lutidine (18.33 mmol, 5 equiv.) 
followed by 2.5 mL of tert-butyldimethylsilyl trifluoromethansulfonate (11 mmol, 3.0 equiv.) 
TMS
OTBS
MeTBSO
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dropwise via syringe. The resulting solution was allowed to warm to ambient temperature and 
stirred for 3 h. The reaction mixture was then quenched with 10 mL of saturated NaHCO3 
solution and 10 mL of brine solution. After separation of layers, the aqueous layer was extracted 
with CH2Cl2 (5 x 30 mL). The combined organics were dried over Na2SO4 and concentrated in 
vacuo. The crude product was product was purified by flash chromatography (2% EtOAc in 
hexanes) to yield 1.20 g of the title compound (80% yield) as a colorless oil: [α]D =  +5.5 (c 1.2, 
CHCl3); IR (thin film): 2956, 2929, 2886, 2857, 2166, 1472, 1252, 1117, 1093, 837 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 3.90–3.79 (m, 2H), 1.96–1.80 (m, 2H), 1.43 (s, 3H), 0.91 (s, 9H), 
0.86 (s, 9H), 0.16 (s, 9H), 0.15 (s, 6H), 0.07 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 109.7, 88.3, 
67.9, 60.3, 54.9, 47.5, 31.5, 26.0, 25.7, 18.4, 18.0, –0.2, –2.9, –3.2, –5.2; EI-MS e/v 399 (M+–
CH3), 357 (M+–tBu), 329, 255, 189, 147; HRMS calcd for C20H43O2Si3: 399.2571 found 
399.2560. 
 
(R)-3-(tert-Butyldimethylsilanyloxy)-3-methyl-5-trimethylsilanylpent-
4-yn-1-ol (85b): To a solution of 2.30 g of tert-butyldimethylsilyl ether 
85a (5.55 mmol) in a 9:1 solvent mixture of THF: H2O (20 mL) added 0.12 g of DDQ (0.55 
mmol, 10 mol %) at ambient temperature. After 6 h the reaction mixture was concentrated in 
vacuo and the crude product was purified by flash chromatography (1% EtOAc in hexanes) to 
afford 1.58 g of the title compound (95% yield) as a colorless oil: [α]D =  +20.8 (c 1.50, CHCl3); 
IR (thin film): 3350, 2957, 2930, 2857, 2167, 1472, 1251, 1121, 1041, 839 cm-1; 1H NMR (300 
MHz, CDCl3): δ 3.94 (ddd, J = 11.3, 5.0, 5.0 Hz, 1H), 3.84 (ddd, J = 11.1, 6.0, 6.0 Hz, 1H), 2.77 
(dd, J = 5.5, 5.5 Hz, 1H), 1.93–1.88 (m, 2H), 1.49 (s, 3H), 0.87 (s, 9H), 0.23 (s, 3H), 0.22 (s, 
3H), 0.17 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 109.4, 89.5, 69.9, 60.2, 46.6, 31.2, 25.7, 17.9,  
OH
MeTBSO
TMS
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–0.3, –2.8, –3.2; EI-MS e/v 285 (M+–CH3), 255, 147, 95; HRMS calcd for C14H32O2Si2:  
285.1706 found 285.1715. 
 
(R)-3-(tert-Butyldimethylsilanyloxy)-3-methyl-5-trimethylsilanylpent-
4-ynal (82):  To a 0 °C solution of 1.58 g of alcohol 85b (5.26 mmol) in 
25 mL of CH2Cl2 added 3.35 g of Dess-Martin periodinane (7.89 mmol, 1.5 equiv). The reaction 
mixture was allowed to warm to ambient temperature and stirred for 3 h. It was diuted with 
hexanes and filtered through a short plug of florisil with 5% EtOAc in hexanes. After removal of 
solvents in vacuo the crude product was purified by flash chromatography (5% EtOAc in 
hexanes) to obtain 1.32 g of the title compound (84% yield) as a colorless oil: [α]D =  +36 (c 1.4, 
CHCl3);  IR (thin film): 2958, 2930, 2857, 1730, 1251, 1115, 1040, 838, 777 cm-1; 1H NMR (300 
MHz, CDCl3): δ 9.88 (t, J = 2.9 Hz, 1H), 2.58 (br d, J = 2.4 Hz, 2H), 1.54 (s, 3H), 0.86 (s, 9H), 
0.21 (s, 6H), 0.18 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 201.9, 107.9, 90.4, 66.6, 56.9, 31.3, 
25.5, 17.9, –0.4, –2.9, –3.3; EI-MS e/v  283 (M+–Me), 255 (M+–CH3–CO), 241, 147; HRMS 
calcd for C14H27O2Si2:  283.1549 found 283.1556. 
CHO
MeTBSO
TMS
 
 
 
(4S,2R)-4-[2-(tert-Butyldimethylsilanyloxy)-2-methyl-4- 
trimethylsilanyl-but3-ynyl]-oxetan-2-one (81): To a solution of   
O
O
TMS
TBSO Me
0.036 g of triamine ligand precursor to catalyst 63 (0.067  mmol) in 1.0 mL of CH2Cl2 was added 
0.04 mL of a 2 M in hexanes solution of trimethylaluminum (0.074 mmol) and was  stirred for 2 
h. The solution was cooled to –50 °C, and 0.12 mL of iPr2NEt (1.14 mmol) was added to it 
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followed by the slow addition of 0.09 mL of acetylbromide (1.27 mmol). To the resulting pale 
yellow solution was added 0.200 g of aldehyde 82 (0.67 mmol) in 1.5 mL of CH2Cl2.  The 
reaction mixture was stirred overnight at –50 °C, poured into cold hexanes and filtered through a 
short plug of silica gel with 30% EtOAc in hexanes. The filtrate was concentrated and the crude 
product was purified by flash chromatography on silica (1% EtOAc in hexanes) to afford 0.200 g 
of lactone 81 (88%) as a colorless oil: [α]D = +30 (c 2.3, CHCl3); IR (thin film): 2957, 2930, 
2857, 2169, 1835, 1251, 1165, 1125, 1077, 868 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.83 (dddd, 
J = 8.8, 5.7, 4.2, 4.2 Hz, 1H), 3.57 (dd, J = 17, 5.7 Hz, 1H), 3.29 (dd, J = 17, 4.2 Hz, 1H), 2.32 
(dd, J = 14, 4.2 Hz, 1H), 2.03 (dd, J = 14, 9.0 Hz, 1H), 1.50 (s, 3H), 0.86 (s, 9H), 0.22 (s, 3H), 
0.19 (s, 9H), 0.15 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 168.5, 107.9, 90.3, 69.1, 67.8, 48.9, 
44.6, 31.6, 31.5, 25.6, 17.9, –0.3, –3.0, –3.1; EI-MS e/v 325 (M+–CH3), 283 (M–CH3–C2H2O), 
255, 241, 143, 101; HRMS calcd for C16H29O3Si2:  325.1655 found 325.1647. 
 
 (3S,5R)-5-(tert-Butyldimethylsilanyloxy)-3-hydroxy-5-
methyl-7-trimethylsilanylhept-6-ynoic acid 
methoxymethylamide (86): To a 0 °C solution of 0.202 g of N,O-dimethylhydroxylamine 
hydrochloride (2.06 mmol) in 8 mL of CH2Cl2, was added 2 mL of dimethylaluminumchloride    
(1 M solution in hexanes) (2.06 mmol) and the resulting solution was allowed to stir at ambient 
temperature for 2 h. To the clear solution was added, 0.350 g of lactone 81 in 2 mL of CH2Cl2, 
slowly. The resulting pale yellow solution was stirred overnight and quenched with 6 mL of pH 
8 phosphate buffer (3 mL/mmol of Me2AlCl). The organic layer was separated, filtered through 
celite, dried over Na2SO4 and concentrated. The crude product was purified by flash 
chromatography (20% EtOAc/Hex) to afford 0.415 g of the title compound (90%) as a colorless 
OH
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oil: [α ]D =  +31.4 (c 22.8, CHCl3); IR (thin film): 3499, 2957, 2930, 2957, 2167, 1651, 1472, 
1251, 1116, 1000, 839, 777 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.45 (dddd, J = 8.6, 5.2, 3.7, 
3.7 Hz, 1H), 3.67 (s, 3H), 3.16 (s, 3H), 2.67 (dd, J = 16.0, 7.7 Hz, 1H), 2.57 (dd, J = 16.0, 5.0 
Hz, 1H), 1.94 (dd, J = 14.2, 8.1 Hz, 1H), 1.85 (dd, J = 14.1, 3.6 Hz, 1H), 1.51 (s, 3H), 0.85 (s, 
9H), 0.19 (s, 6H), 0.14 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 172.7, 109.7, 89.3, 69.2, 65.5, 
61.3, 50.7, 39.4, 31.9, 30.5, 25.7, 17.9, –0.4, –2.9, –3.1; EI-MS e/v 386 (M+–Me), 368 (M+–Me–
H2O), 255, 215; HRMS calcd for C18H36NO4Si2:  386.2182 found 386.2174. 
 
 (3S,5R)-3,5-Bis-(tert-butyldimethylsilanyloxy)-5-methyl-7-
trimethylsilanylhept-6-ynoic acid methoxymethylamide 
(86a):      To a 0 °C solution of 0.367 g of alcohol 86 (0.952 mmol) in 10 mL of CH2Cl2 was 
added 0.267 mL of 2,6-lutidine (2.28 mmol) followed by 0.317 mL of TBSOTf (1.373 mmol) 
and allowed to warm to ambient temperature over 1 h. The reaction mixture was quenched with 
5 mL of NaHCO3. After separation of the layers, the aqueous layer was extracted with CH2Cl2 (3 
x 5 mL). The organics were combined, washed with 5 mL of brine, dried over Na2SO4 and 
concentrated. The crude product was purified by flash chromatography (5% EtOAc in hexanes) 
to afford 0.450 g of the title compound (95%) as a colorless oil: [α]D =  +28.9 (c 2.57 CHCl3); IR 
(thin film) 2956, 2929, 2856, 2166, 1669, 1472, 1446, 1385, 1251, 1075, 993, 837 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 4.59 (dddd, J = 9.0, 9.0, 2.9, 2.9 Hz, 1H), 3.67 (s,3H), 3.16 (s, 3H), 
2.81–2.70 (m, 2H), 1.93 (dd, J = 13.9, 9.2 Hz), 1.81 (dd, J = 13.9, 2.9 Hz, 1H), 1.46 (s,3H), 0.85 
(s, 18H), 0.21 (s, 3H), 0.18 (s, 12H), 0.12 (s, 3H), 0.09 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 
172.7, 109.3, 89.3, 77.2, 68.3, 67.8, 61.2, 52.4, 32.5, 25.9, 25.8, 18.0, 17.9, –0.2, –2.8, –3.1, –4.3, 
OTBS
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–4.7; EI-MS e/v 500 (M+–Me), 458 (M+–tBu), 255, 188, 115, 101; HRMS calcd for C7H13OSi: 
500.3047 found 500.3039.       
 
 (3S,5R)-3,5-Bis-(tert-butyldimethylsilanyloxy)-5-methylhept-6-
ynoic acid methoxymethylamide (87): To a solution of 1.05 g of 
trimethylsilylalkyne 86a (2.04 mmol) in 10 mL of MeOH, was added 0.114 g of KOH (2.04 
mmol) and the solution was allowed to stir at ambient temperature for 5 h. The reaction mixture 
was concentrated, and the crude product purified by flash chromatography (5–8% EtOAc in 
hexanes) to yield 0.840 g of the title compound (93%) as a colorless oil:  [α]D = +28.8 (c 1.20, 
CHCl3); IR (thin film): 3308, 3235, 2955, 2930, 2895, 2106, 1665, 1472, 1463, 1252, 1003, 836, 
777 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.64–4.54 (m, 1H), 3.68 (s, 3H), 3.16 (s, 3H), 2.77 
(app. d, J = 5.0 Hz, 2H), 2.51 (s, 1H), 1.97 (dd, J = 14.0, 8.6 Hz, 1H), 1.85 (dd, J = 14.0, 3.3 Hz, 
1H), 1.50 (s, 3H), 0.86 (s, 18H), 0.20 (s, 3H), 0.18 (s, 3H), 0.10 (s, 3H), 0..05 (s, 3H); 13C NMR 
(75 MHz, CDCl3): δ  172. 6, 87.3, 77.4, 73.0, 67.9, 67.7, 61.2, 52.5, 40.8, 32.4, 25.8, 25.7, 18.0, 
17.9, –2.7, –3.1, –4.5, –4.7 ; EI-MS e/v  428 (M+–Me), 386 (M+–tBu), 317, 257, 183, 115; 
HRMS calcd for C21H42NO4Si2 428.2652 found 428.2646. 
OTBSTBSO Me O
N
Me
OMe
 
 (3S,5R)-3,5-Bis(tert-butyldimethysilanyloxy)-5,6-dimethyl-7-
tributylstannanylhept-6-enoic acid methoxymethylamide 
(88): To a –60 °C suspension of 0.247 g of CuCN (3.02 mmol) in 
THF (1.5 mL)was added 1.9 mL of a 1.6 M solution of nBuLi in hexanes to produce a light 
OTBSTBSO Me O
N
Me
OMeMe
Bu3Sn
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brown solution which was allowed to warm to –30 °C over 30 min.  A solution of nBu3SnLi was 
prepared by adding nBuLi (1.6 M solution in hexanes) to a solution of 1.873 g of bis(tributyltin) 
(3.23 mmol) in 1 mL of THF at –30 °C. This solution was cannulated into the cuprate solution 
with 3 mL of THF. A dark yellow solution was formed which was stirred at –30 °C for 2 h, 
cooled to –50 °C, whereupon a solution of 0.445 g of alkyne 87 was added to it via syringe. This 
was stirred for 10 min and then 1 mL of MeI (excess) was added to it. The solution developed a 
red color and was allowed to warm to ambient temperature overnight. The reaction mixture was 
diluted with ether, and 10 mL of a saturated solution of NH4Cl was added to it, and the aqueous 
layer was extracted with ether (3 x 20 mL). The organics were combined, dried over Na2SO4 
concentrated, and the crude product was purified by flash chromatography (1% Et3N, then 0.2–
0.5% EtOAc in hexanes) to afford 0.625 g of the title compound as a pale yellow oil: [α]D = 
+17.7 (c 1.60, CHCl3); IR (thin film) 2956, 2928, 2855, 1671, 1463, 1384, 1254, 1123, 1084, 
835, 774 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.83 (s, JSn-H = 69.7Hz, 1H), 4.16 (dddd, J = 6.6, 
6.6, 6.6, 6.6 Hz, 1H), 3.65 (s, 3H), 3.14 (s, 3H), 2.80 (app d, J = 4.9 Hz, 2H), 1.86–1.83 (m, 2H), 
1.81 (s, 3H), 1.55–1.44 (m, 9H), 1.30 (app sextet, J = 7.29 Hz, 6H), 0.95–0.85 (m, 15H), 0.89 (s, 
9H), 0.84 (s, 9H), 0.10 (s, 3H), 0.05 (s, 3H), 0.04 (s, 3H), 0.01 (s, 3H). 13C NMR (75 MHz, 
CDCl3): δ 172.4, 157.4, 122.5, 79.0, 67.3, 61.1, 50.2, 40.6, 29.2, 29.1, 28.8, 27.3, 26.7, 25.8, 
21.7, 18.5, 18.0, 13.6, 10.0, –1.0, –2.2, –4.2, –4.5 ; HRMS calcd for C35H75NO4Si2Sn 749.4257 
found 749.4294.  
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3,5-Bis-(tert-butyldimethylsilanyloxy)-5,6-dimethyl-7-
trimethylstannanylhept-6-enoic acid methoxymethylamide 
(89): To a –60 °C suspension of 0.1026 g of CuCN (1.13 mmol) 
in THF (1.2 ml), was added 0.71 mL of nBuLi (1.6 M solution in hexanes). The light brown 
colored solution was stirred and allowed to warm to –30 °C. A solution of Me3SnLi was 
prepared by the addition of 0.8 mL of nBuLi (1.6 M solution in hexanes) to a –30 °C solution of 
0.386 g of hexamethylditin (1.18 mmol) in THF (0.3 mL) and stirring the resulting solution for 
30 min at –30 °C. The Me3SnLi thus made was cannulated into the cuprate solution at –30 °C, 
after which the yellow suspension was maintained at that temperature for 1.5 h. The reaction 
mixture was cooled to –50 °C, a solution of 0.100 g of alkyne 87 (0.23 mmol) in THF (1.2 mL) 
was added to it, followed by the addition of 0.3 mL of methyliodide (4.53 mmol). The solution 
was allowed to warm to ambient temperature overnight.  To the reaction mixture was added 0.2 
mL of a saturated solution of NH4Cl, stirred for 10 min, and the aqueous layer extracted with of 
ether (3 x 5 mL). The organics were combined, dried over Na2SO4, concentrated, and purified by 
flash chromatography on silica gel (0.2–0.5% EtOAc in hexanes with 5% Et3N) to afford 0.090 g 
of stannane 89 (64%) as a bright yellow oil. [α]D = +15.3 (c 1.00, CHCl3); IR (thin film) 2956, 
2928, 2856, 1667, 1471, 1462, 1384, 1254, 1003,  834, 773   cm-1; 1H NMR (300 MHz, CDCl3): 
δ 5.85 (s, JSn-H = 77.0 Hz, 1H), 4.46–4.38 (m, 1H), 3.66 (s, 3H), 3.16 (s, 3H), 2.67 (d, J = 4.5 Hz, 
2H), 1.96 (dd, J = 14.1, 4.8 Hz, 1H), 1.83 (t, J = 5.0 Hz, 3H), 1.69 (dd, J = 14.1, 3.5 Hz, 1H), 
1.45 (s, 3H), 0.90 (s, 9H), 0.84 (s, 9H), 0.15 (s, JSn-H = 54.1 Hz, 9H), 0.10 (s, 3H), 0.07 (s, 3H), 
0.02 (s, 6H). 13C NMR (75 MHz, CDCl3): δ 172.7, 159.3, 122.6, 78.4, 77.0, 67.4, 61.3, 50.2, 
40.4, 27.5, 26.3, 26.0, 21.1, 18.7, 18.0, –1.4, –2.5, –4.3, –4.5, –8.9; EI-MS e/v 608 (M+–Me), 566 
(M+–tBu), 286, 188, 165; HRMS calcd for C25H54NO4Si2Sn: 608.2586, found 608.2591. 
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  (3S,5R)-3,5-Bis(tert-butyldimethylsilanyloxy)-7-iodo-5,6-
dimethylhept-6-enoic acid methoxymethylamide (90):  To a 
solution of 0.021 g of stannane 88 in 5mL of CH2Cl2 was added 0.007 g of I2 in portions. After 
10 min, the solvent was evaporated in vacuo and the crude product purified by flash 
chromatography on silica gel (2% EtOAc in hexanes) to yield 0.016 g of iodide 90 (98%) as a 
pale yellow oil: [α]D = +8.1 (c 0.6, CHCl3); IR (thin film) 2956, 2929, 2856, 1660, 1471, 1386, 
1256, 1002, 835 cm-1; 1H NMR (300 MHz, CDCl3): δ 6.32 (s, 1H), 4.14 (quintet, J = 6.1 Hz, 
1H), 3.67 (s, 3H), 3.16 (s, 3H), 2.65 (dd, J = 14.6, 7.7 Hz, 1H), 2.53 (dd, J = 5.9, 14.6 Hz, 1H), 
1.90–1.87 (m, 2H), 1.88 (s, 3H), 1.48 (s, 3H), 0.89 (s, 9H), 0.85 (s, 9H), 0.12 (s, 3H), 0.06 (s, 
3H), 0.02 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 172.1, 151.6, 78.8, 78.7, 77.5, 66.7, 61.2, 49.6, 
28.6, 26.1, 25.9, 22.1, 18.5, 17.9, –1.5, –2.1, –4.1, –4.3; EI-MS e/v 570 (M+–Me), 528 (M+–tBu), 
188, 165; HRMS calc for C22H45INO4Si2: 570.1932, found 570.1955.  
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Proof of regiochemistry using DEPT and nOe  studies: 
MeTBSO OTBSO
N
Me
OMeMe
I
13C signal: 78.7 (C-H)
13C signal: 151.6 (C(q))
NOESY cross peaks observed
 
 
(S)-4,8-dimethylnon-7-en-2-one (96a) [39]: 1H NMR (300 MHz, 
CDCl ): δ 5.00 (dd, J = 4.5, 4.5 Hz, 1H), 2.34 (dd, J = 15.7, 5.5 Hz, 1H), 2.13 
(dd, J = 15.8, 8.1 Hz, 1H), 2.04 (s, 3H), 1.96–1.82 (m, 3H), 1.59 (s, 3H), 1.51 
(s, 3H), 1.28–1.07 (m, 2H), 0.82 (d, J = 6.6 Hz, 3H);  
3
13C NMR (75 MHz, CDCl ): δ 208.6, 
131.1, 124.1, 50.9, 36.7, 30.1, 28.7, 25.5, 25.2, 19.5, 17.4. 
3
 
(S)-4,8-dimethylnona-1,7-dien-2-yl trifluoromethanesulfonate (96): To a    
–78 °C solution of 5.2 mL of a 0.5 M solution of 
potassiumbis(trimethylsilyl)amide in toluene (2.6 mmol) in THF (8 mL) was 
added a solution of 0.36 g of ketone 96a (2.2 mmol) in THF (3 mL), dropwise. The resulting 
solution was stirred at –78 °C for 15 min and then, a solution of 0.85 g (2.4 mmol) of N-
phenyltriflimide in THF (4 mL) was cannulated into the reaction mixture to produce a yellow 
solution which was then allowed to warm to 0 °C. Then,   10 mL of a saturated NaHCO3 solution 
Me
OTf
Me
O
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and 20 mL of ether were added to it, the layers were separated, and the aqueous layer washed 
with ether (5 x 20 mL). The combined organics were dried over Na2SO4, concentrated and 
purified by column chromatography over silica gel (0.5% EtOAc in hexanes, 2% Et3N) to afford 
0.55 g (85%) of the title compound as a colorless oil: [α]D = –7.2 (c 1.4, CHCl3); IR (thin film) 
2966, 2919, 1670, 1419, 1249, 1141, 941 cm -1;  1H NMR (300 MHz, CDCl3): δ 5.13 (d, J = 3.4 
Hz, 1H), 5.12–5.06 (m, 1H), 4.92 (d, J = 15.2, 6.0 Hz, 1H), 2.37 (dd, J  = 15.2, 6.0 Hz, 1H); 
2.15–1.93 (m, 3H), 1.82–1.75 (m, 1H), 1.69 (s, 3H), 1.61 (s, 3H), 1.40 (dddd, J = 13.4, 9.1, 5.5, 
5.5 Hz, 1H), 1.22 (dddd,  J = 13.9, 8.1, 6.5, 6.5 Hz, 1H), 0.98 (d, J = 7.7 Hz, 3H); 13C NMR (75 
MHz, CDCl3): δ 155.9, 131.8, 124.0, 118.4 (q, JC-F = 322 Hz), 105.2, 41.4, 36.3, 29.6, 25.6, 25.2, 
19.0, 17.6; HRMS calcd for C12H19O3F3S: 300.1007, found 300.1011.  
 
4,4,5,5-tetramethyl-2-[(S)-4,8-dimethylnona-1,7-dien-2-yl]-1,3,2-
dioxaborolane (97): A mixture of 0.103 g of triflate 96 (0.34 mmol), 0.10 g 
of bis(pinacolato)diboron (0.37 mmol, 1.1 equiv), 0.056 g of 
bis(triphenylphosphine)palladium dichloride (0.088 mmol, 10 mol %), 0.042 
g of triphenylphosphine (0.160 mmol, 20 mol %) and 0.154 g of potassium phenoxide (1.20 
mmol, 1.5 equiv) in 5 mL of toluene (0.2 M) was heated at 50 °C for 3 h. After cooling the 
reaction mixture to ambient temperature, added 2 mL of water, 20 mL of ether, separated the 
layers and extracted the aqueous layer with ether (3 x 10 mL). The organics were combined, 
dried over Na2SO4, concentrated and the crude product purified by column chromatography over 
silica gel (1% EtOAc in hexanes, 1% Et3N) to afford 0.067 g (70%) of the title compound as a 
colorless oil: [α]D = –6.5 (c 1.2, CHCl3); IR (thin film): 3061, 2977, 2924, 1614, 1444, 1344, 
1307, 1185, 1143, 941 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.79 (d, J = 3.6 Hz, 1H), 5.56 (d, J = 
Me
B O
O
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3.1 Hz, 1H), 5.11 (ddq, J = 4.6, 4.6, 1.2 Hz, 1H), 2.18 (dd, J = 13.0, 6.1 Hz, 1H), 2.04–1.94 (m, 
3H), 1.68 (s, 3H), 1.60 (s, 3H), 1.44–1.33 (m, 2H), 1.26 (s, 12H), 1.14–1.08 (m, 1H), 0.84 (d, J = 
6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 130.7, 130.0, 125.0, 83.2, 43.2, 36.8, 32.2, 25.7, 
25.5, 24.7, 24.6, 19.4, 17.6; HRMS calcd for C17H31BO2: 278.2417, found 278.2423.  
 
 
General procedure for Suzuki coupling (A): A mixture of of iodide 90, boronic ester, 
palladium(dppf)dichloride [or palladiumbis(acetonitrile)dichloride and dppf] was evacuated and 
refilled under nitrogen twice. To this was added DMF and barium hydroxide followed by 2 rapid 
evacuation and N2 refilling cycles. The resulting yellow solution was stirred at 45 °C for 30 min, 
during which time it developed a dark brown color. The reaction mixture was worked up by 
dilution with ether and the addition of 0.5 mL of H2O. After separation of the layers, the aqueous 
layer was extracted with ether (3 x 5 mL). The organics were combined, dried over Na2SO4, 
concentrated in vacuo, and the crude product was purified by flash chromatography.  
 
 
(E)-(3S,5R,10S)-3,5-Bis-(tert-butyldimethylsilanyloxy)-
5,6,10,14-tetramethyl-8-methylenepentadeca-6,13-dienoic 
acid methoxymethylamide (100): General procedure A was 
followed with 30 mg of iodide 90 (0.04 mmol), 24 mg of 
boronic acid 97 (0.08 mmol, 1.8 equiv), 3.9 mg of Pd(CH3CN)Cl2 (0.01 mmol, 30 mol %), 8.5 
mg of dppf, and 48.5 mg of Ba(OH)2 (0.15 mmol, 3 equiv). Isolated 18 mg of diene 100 (64%) as 
a colorless oil: [α]D = –7.5 (c 1.0, CHCl3); IR (thin film): 2955, 2928, 1669, 1472, 1255, 1128, 
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1015, 834 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.88 (s, 1H), 5.09 (ddq, J = 7.1, 7.1, 1.3 Hz, 1H), 
4.99 (br s, 1H), 4.84 (br s, 1H), 4.17 (dddd, J = 8.4, 8.4, 5.9, 5.9 Hz, 1H), 3.66 (s, 3H), 3.14 (s, 
3H), 2.65–2.60 (m, 2H), 2.11 (dd, J = 13.6, 6.4 Hz, 1H), 1.94–1.88 (m, 6H), 1.80 (s, 3H), 1.68 (s, 
3H), 1.60 (s 3H), 1.45 (s, 3H), 1.14–1.09 (m, 2H), 0.90 (s, 9H), 0.84 (s, 9H), 0.83 (d, J = 6.8 Hz, 
3H), 0.12 (s, 3H), 0.06 (s, 3H), 0.02 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 172.4, 145.2, 141.4, 
130.9, 125.7, 125.0, 114.4, 77.8, 77.4, 67.2, 61.2, 50.0, 46.0, 40.5, 37.0, 31.9, 31.0, 28.6, 26.2, 
25.9, 25.6, 19.4, 18.5, 17.9, 17.6, 15.0, –1.5, –2.1, –4.5, –4.6; HRMS calcd for C34H67NO4Si2: 
609.4608, found 609.4620. 
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3.0  COMPLETION OF A C1–C20 FRAGMENT AND THE SECOND GENERATION 
APPROACH 
3.1 ALTERNATE SYNTHESIS OF THE C7–C13 FRAGMENT 
From our previous studies, we had learned that conversion of the triflate functionality to a 
boronic ester in the C7–C13 fragment of amphidinolide B had to precede the installation of the 
C7–C8 double bond. A short alternate synthesis of the C7–C13 fragment was hence realized 
starting with an AAC reaction of 2-tert-butylsilanyloxy propionaldehyde [43] with acetyl 
bromide in the presence of Al(III) triamine catalyst 63a, [44] delivering β-lactone 102 in 86% 
yield and 95% ee. [45] β-lactone 102 was subjected to cuprate-mediated ring opening with 
methylmagnesiumbromide to give carboxylic acid 103 in 77% yield. A two step sequence of 
conversion to the Weinreb amide with N,O- dimethylhydroxylamine and subsequent reaction 
with methyllithium formed methyl ketone 104 in 81% overall yield. Functionalization of ketone 
104 to a boronate ester was done by conversion to triflate 105 following kinetic enolization and 
trapping with N-phenyltriflimide (89% yield) and subsequent application of Miyaura’s procedure 
to form boronic ester 106 in 79% yield from triflate 105. [40] A four step sequence of silyl group 
deprotection using TBAF, Dess-Martin oxidation to the aldehyde, [31] Horner-Wadsworth-
Emmons reaction [23] and Dibal-H mediated reduction to the alcohol afforded allylic alcohol 
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107 in 57% overall yield. Protection of the primary alcohol 107 with a tert-butyldmethylsilyl 
group proceeded in 91% yield to afford silyl ether 108. 
  
Scheme 11: Alternate synthesis of the C7–C13 fragmenta 
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3.2 DIENE FORMATION IN THE REAL SYSTEM 
3.2.1 Suzuki coupling studies with the C7–C13 fragment 
With boronate esters 106a, 107 and 108 in hand, the optimized Suzuki cross-coupling 
conditions were applied to evaluate the efficiency of formation of the C13–C15 diene in the real 
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system (Eq 5). Hence, with palladium(dppf) dichloride as the catalyst, barium hydroxide as the 
base and heating at 45 °C in DMF produced desired dienes 109, 110, and 111 respectively. The 
reaction showed tolerance to a free hydroxyl group as shown by the reaction with fragment 106a 
yielding diene 109 in 84% yield. The presence of a primary allylic alcohol in boronate ester 107, 
however, slowed down the cross-coupling considerably, presumably by coordination to the 
palladium, resulting in a poor yield of the desired diene 110 of 39%. The corresponding α, β-
unsaturated aldehyde formed by oxidation of the allylic alcohol in diene 110 was also isolated in 
10 % yield. Protection of the free hydroxyl group with a tert-butyldimethylsilyl group, however, 
solved this problem and diene 111 from boronic ester 108 was obtained in an excellent yield of 
94%. 
 
 
R
Me
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boronate ester                           Isolated yield of diene 
    (R = )
CH2OH (106a)
(E)-CH=CHCH2OH (107)
(E)-CH=CHCH2OTBS (108)
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(109) 82%
(110) 39%a
(111) 94%
30 mol % Pd(dppf)Cl2
3.0 Ba(OH)2.8H2O
DMF, 45 °C
90
a. 10% of the α, β- unsaturated aldehyde was isolated as a byproduct
 
 
 (5) 
 
 
 
 
 
 
 
 
 
 
 
 
 65 
3.2.2 Diene instability under Sharpless’ epoxidation conditions 
With diene 111 in hand, we decided to incorporate in it the C8–C9 epoxide functionality 
via the asymmetric Sharpless’ epoxidation reaction. Accordingly, the primary tert-
butyldimethylsilyl group was removed using HF/pyridine conditions, and allylic alcohol 112 was 
obtained in 80% yield. Allylic alcohol 112 was then subjected to Sharpless’ epoxidation 
conditions [29] with titanium isopropoxide, (+)-diethyl tartarate, and tert-butylhydroperoxide. 
Although the desired epoxidation reaction took place, the diene in the product underwent 
isomerization under the reaction conditions and the more stable diene 113 was isolated.  
Presumably, titanium isopropoxide behaved as a Lewis-acid and facilitated isomerization of the 
diene to the internal position. 
 
Scheme 12: Sharpless' epoxidation of allylic alcohol 112 
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3.2.3 Modification of the epoxide fragment and completion of the C7–C20 fragment 
In light of the instability of the C13–C15 diene towards Sharpless’ epoxidation conditions, 
we decided to try incorporating the epoxide moiety earlier in the sequence, before the formation 
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of the C13–C14 bond. This would also serve to increase convergence in the sequence of steps. 
Epoxidation of an allylic alcohol in the presence of a vinyl boronic ester was, however, 
unprecedented. Another important factor was to check the viability of the Suzuki cross-coupling 
reaction in the presence of epoxide functionality.  
 
Upon subjecting allylic alcohol 107 to Sharpless’ epoxidation conditions using            
(+)-diethyl tartarate ligand, the corresponding epoxide was obtained in which the primary 
alcohol was protected with a tert-butyldimethylsilyl group to afford silyl ether 114 in an overall 
yield of 58% (Scheme 13). We were also pleased to find that the Suzuki cross-coupling reaction 
of boronate ester 114 with iodide 90 under the optimized conditions proceeded smoothly to 
afford diene 115 in 80% yield without any complications arising from the epoxide.   
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Scheme 13: Completion of a C7–C20 fragment of amphidinolide Ba 
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3.2.4 Completion of a C1–C20 synthon 
Having shown that we could efficiently couple two major fragments 90 and 114 to form a 
C7–C20 synthon which constitutes the “left” portion of amphidinolide B, we wanted to investigate 
the coupling of this fragment with sulfone fragment 65 via a Julia olefination reaction. The 
primary silyl group in diene 115 was selectively removed by treatment with pyridine-buffered 
HF and the free hydroxyl group was oxidized with pyridine-buffered Dess-Martin reagent to 
yield aldehyde 116 in an overall yield of 53% (Scheme 14). Kocienski-modified Julia olefination 
conditions were applied; [46] sulfone 65 was deprotonated with potassium 
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bis(trimethylsilyl)amide at –55 °C in DME and then aldehyde 116 was added to it to afford 
epoxy alkene 117 in 51% yield as a 2:1 mixture of E:Z isomers.  
 
Scheme 14: Elaboration of 115 to a C1–C20 synthona 
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3.3 SHORTCOMINGS OF THE FIRST GENERATION APPROACH 
3.3.1 Completion of the C14–C26 fragment 
Concurrent with our studies on the formation of the C13–C15 diene of amphidinolide B, 
we undertook studies to form the C14–C26 fragment which constitutes the “upper fragment” of 1. 
Optimized conditions were found to open β-lactone 81 with the lithium anion of dimethylmethyl 
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phosphonate to form the corresponding β-ketophosphonate 68 in 90% yield (Scheme 15). [47] 
The C22–C26 aldehyde fragment 69 was generated according to previously reported literature 
procedures [11] and then coupled with phosphonate 68 under Roush-Masamune conditions to 
afford unsaturated ketone 118 in 70% yield, which then served as the precursor for Sharpless’ 
dihydroxylation to install the C21–C22 syn diol unit of amphidinolide B. Dihydroxylation of 
enone 118 with the Sharpless’ reagent system [48] (AD mix-α, 10 mol % K2OsO4.2H2O, 10 mol 
% (DHQ)2PHAL, NaHCO3, MeSO2NH2, tBuOH/H2O)  proceeded in moderate yields (42–50%) 
to deliver diol 119. This sequence completed the installation of the six requisite stereocenters in 
the C14–C26 fragment of 1. 
 
Scheme 15: Synthesis of the C14–C26 fragmenta 
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3.3.2 Sensitivity of the C21- α-keto stereocenter 
Completion of a fully functionalized “upper fragment” of amphidinolide B was 
predicated on the installation of a trisubstituted alkene moiety in the place of the C14–C15 alkyne 
in diol 119. Prior to the carbometallation of the alkyne, protection of the diol and deprotection of 
the alkynyl trimethylsilyl group remained to be accomplished.  However, we found that under 
conditions for protection of the diol (excess TBSOTf, lutidine, CH2Cl2, 0 °C) the C21- 
stereocenter underwent partial or complete racemization (Scheme 16). Moreover, subjecting a 
single diastereomer of bis-protected compound 120 to alkyne trimethylsilyl deprotection 
conditions (silver nitrate, lutidine, water, ethanol) also led to epimerization of C21- α-keto 
stereocenter. Presumably, exposure of the α-keto stereocenter to Lewis-acidic conditions in the 
presence of an organic base i.e. lutidine facilitated easy epimerization of that stereocenter 
through soft-enolization and protonation steps. 
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Scheme 16: Lability of the C21 stereocenter 
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3.4 THE SECOND GENERATION APPROACH TO AMPHIDINOLIDE B- THE 
ALDOL STRATEGY 
3.4.1 Revised retrosynthesis- homologation through Weinreb amide 90 
The lability of the C21- stereocenter under conditions required to deprotect the alkynyl 
trimethylsilyl group and install the C14–C15 trisubstituted alkene led us to explore other routes 
that would allow the carbometallation reaction to take place prior to the coupling of fragments to 
complete the top half of 1. As an alternate approach to constructing the top fragment, we 
considered the formation of the C21–C22 bond via a stereoselective aldol reaction between 
glycolate 122 and aldehyde 69 (Figure 15). Stereoselectivity would be dictated by a Felkin 
approach on the α-chiral aldehyde and a Zimmerman-Traxler transition state employing a          
Z-boron enolate would ensure a syn diol relationship across the C21–C22 bond. 
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 According to our revised retrosynthetic analysis, fragment 121 would be obtained after 
the first two disconnections across the C1–O bond and the C6–C7 bond via macrolactonization 
and Julia olefination reactions respectively. Further, disconnection across the C13–C14 bond via 
Suzuki cross-coupling and across the C21–C22 bond via a glycolate aldol reaction gave ketone 
122, boronate ester 114 and aldehyde 69. α-Alkoxy ketone 122 would be formed from Weinreb 
amide 90 by the addition of an α-alkoxyl methyllithium species to it. 
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Figure 15: Revised retrosynthetic analysis of Amphidinolide B- the aldol approach 
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3.4.2 Synthesis of precursors for aldol study 
As a two-fold approach to the aldol reaction we decided to prepare enolate precursors 
arising from iodide 90 as well as diene 115. Weinreb amide 90 was reduced to aldehyde 123 by 
diisobutylaluminum hydride in 90% yield (Scheme 17). Subsequently, the lithium anion of 
paramethoxybenzyloxymethane obtained by the tin-lithium exchange of 
(paramethoxybenzyoxy)tributylstannane [49] was added to aldehyde 123 and the resulting free 
alcohol was oxidized to ketone 124 by Dess-Martin periodinane in an overall yield of 56%.  
 
Scheme 17: Synthesis of precursor 124 for aldol studya 
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Synthesis of glycolate 125 resulted from the Suzuki cross-coupling of iodide 124 with 
boronic ester 114 under the previously optimized conditions (Eq 6). Although we were able to 
isolate diene 125 in 44–50% yields, the presence of the C20- ketone functionality led to 
elimination of the C18- β-silyloxy group in the product to give 21–30% of undesired enone 126 
as a byproduct. 
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(6) 
 
 
 
 
 
 
 
 
 
3.4.3 Glycolate aldol trials  
α-alkoxy ketones 124 and 125 were individually subjected to typical soft-enolization 
conditions for generating Z-enolates i.e. dibutylboron triflate, Hunig’s base at –78 °C in CH2Cl2 
and then reacted with aldehyde 69 (Eq 7). Disappointingly, both reactions resulted in 
decomposition of the starting material glycolates. While the stability of vinyl iodide functionality 
to boron-based Lewis acids is not well documented in the literature, a sharp color change from 
colorless to deep red upon addition of dibutylboron triflate to iodide 124 in CH2Cl2 led us to 
believe that complications in the reaction could be arising because of the presence of the vinyl 
iodide moiety. Decomposition of diene 125 possibly occurred by isomerization of the 1, 1-
disubstituted diene to the more stable internal position and/or reactivity of the sensitive C7–C8 
epoxide.   
I
Me
Bpin
OTBS
O
MeTBSO O
Me OPMB
Me
OTBS
O
MeTBSO O
OPMBMe
Me
OTBS
O
+
44–50%
21–30%
30 mol % Pd(dppf)Cl2
3.0 Ba(OH)2.8H2O
DMF, 45 °C
+
124
114
125
126
 75 
 
MeTBSO OTBSO
Me
R
OPMB
R = I      124
or
O
Me
OTBS
125
Bu2BOTf
iPr2NEt, then 69
CH2Cl2, –78 °C
decomposition (7) 
 
 
 
 
 
 
 
We did not attempt to test the glycolate aldol coupling strategy in any of the 
intermediates that precede iodide 124 since we would encounter the problem of epimerization of 
the C21- alkoxide bearing stereocenter while attempting to transform the C14–C15 alkyne to the 
trisubstituted alkene functionality.  
3.5 THE DITHIANE ROUTE FOR FRAGMENT COUPLING 
3.5.1 Alternate coupling strategy to form the C14–C26 fragment 
As an alternate means of forming the complete C14–C26 fragment we decided to explore 
the viability of forming the C20–C21 bond. We envisioned that the fully functionalized top half 
127 would result from carbometalation of the alkynyl silyl-deprotected form of fragment 128 in 
which the C20- ketone would be protected as a dithiane (Figure 16). Fragment 128 would result 
from the addition of the anion derived from dithiane 129 into aldehyde 130 followed by 
protection of the newly formed hydroxyl group. The presence of a chelating alkoxy group in the 
 76 
α position of the aldehyde would ensure formation of the correct stereochemistry at the C21 
carbon through a chelate-Cram transition state. [50]  
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Figure 16: Retrosynthesis of the C14–C26 fragment- the dithiane approach 
 
3.5.2 Synthesis of aldehyde fragment 130 and dithiane 129 
Synthesis of the requisite fragment 130 started with aldehyde 76 available through our 
AAC methodology (Scheme 18). Conversion of aldehyde 76 to epoxy alcohol 131 proceeded in 
the three steps of Wittig homologation, diisobutylaluminum hydride-mediated reduction and 
Sharpless’ epoxidation, previously reported in the literature. [51] Epoxide 132 was 
regioselectively methylated with trimethylaluminum [52] and the primary alcohol in the resulting 
diol was selectively protected with a paramethoxybenzyl group to afford alcohol 133 in 53% 
overall yield. The C2- hydroxyl bearing stereocenter was inverted through a Mitsunobu reaction 
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yielding alcohol 133 in 86% yield. [53] Protection of the 2° alcohol with a benzyl group, 
selective deprotection of the paramethoxybenzyl group with DDQ was followed by oxidation of 
the resulting primary alcohol under Swern oxidation conditions to furnish aldehyde 130 in 57% 
yield over 3 steps. 
 
Scheme 18: Synthesis of aldehyde 130 for dithiane trialsa 
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Weinreb amide 86a was reduced with diisobutylaluminum hydride to the corresponding 
aldehyde which was then converted to dithiane 129 by treatment with propane 1, 3-dithiol, 
titanium tetrachloride in CH2Cl2 in 55% yield (Eq 8). 
 
 
OTBSMeTBSO S
S
TMS
OTBSMeTBSO
TMS
O
N
OMe
Me
i. Dibal-H, CH2Cl2, –78 °C
ii. HS(CH2)3SH, 
   10 mol % TiCl4, CH2Cl2, 
 –10 °C–RT
86a 129
55%
 
         (8) 
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3.5.3 Dithiane reaction trials 
With dithiane 129 and aldehyde 130 in hand, we attempted lithiation of the dithiane and 
subsequent addition to aldehyde 130 under various conditions (Eq 9). Unfortunately, we were 
unable to find conditions to metalate dithiane 129. Treatment of excess dithiane 129 with 
butyllithium at –50 °C in THF and addition of aldehyde 130 led to the recovery of the dithiane 
and the addition product of butyl anion into aldehyde 130. We then subjected dithiane 129 to 
metalation with tert-butyllithium in THF at –50 °C and allowed the reaction mixture to warm to 
ambient temperature to facilitate metalation, and then added aldehyde 130 at –50 °C. This led to 
the complete recovery of dithiane 129 and decomposition of the aldehyde. Even metalation with 
butyllithium in the presence of HMPA additive at –50 °C and subsequent addition of aldehyde to 
the reaction mixture failed to produce any product and resulted in the recovery of dithiane 129 
and aldehyde 130.  
 
  
     
(9) 
 
 
 
 
 
The unsuccessful attempts to add the anion of dithiane 129 into aldehyde 130 prompted 
us to perform control experiments to trap the anion with other, more reactive electrophiles such 
as TMSCl. Under a variety of conditions with bases such as butyllithium, tert-butyllithium, 
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(b) tBuLi, THF,  –50 °C – RT, then –50 °C, 130
(c) BuLi, HMPA, –50 °C, then 130
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potassium bis(trimethylsilyl)amide, experiments to metalate dithiane 129 and trap the anion with 
TMSCl led to the complete recovery of intact 129. At this point, we do not have an explanation 
for the resistance of dithiane 129 towards metalation; and in order to proceed with our synthesis 
goals we have decided to abandon this route for the formation of the C14–C26 fragment of 1.  
3.6 CONCLUSIONS 
In pursuit of a total synthesis of the cytotoxic macrolide amphidinolide B (1), asymmetric 
AAC reactions have been used to set key stereochemical relationships in major fragments 90 and 
114. An efficient method to couple two major fragments to form the C13–C15 trisubstituted diene 
in 1 was found and applied in the synthesis of the C7–C20 fragment 115. Subsequent 
homologation was achieved through a Julia olefination reaction to complete a C1–C20 synthon, 
117. Alternate coupling strategies in forming the C21–C22 bond and the C20–C21 bond were 
investigated.  
EXPERIMENTAL SECTION 
O
O
TBSO  (R)-4-[2-(tert-Butyldimethylsilanyloxy)ethyl]oxetan-2-one (102) : To a 
solution of 1.432 g of triamine ligand precursor to catalyst 63a (2.11 mmol) in 18 mL of CH2Cl2 
was added 1.27 mL of trimethylaluminum (2.53 mmol) (2 M solution in hexanes) and was stirred 
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for 2 h. The solution was cooled to –78 °C, and 3.1 mL of iPr2NEt (17.9 mmol) was added to it 
followed by the slow addition of 1.5 mL of acetylbromide (20.1 mmol). To the resulting pale 
yellow solution was added 2.0 g of 3-(tert-butyl-dimethyl-silanyloxy)-propionaldehyde42 (10.6 
mmol) in 6 mL of CH2Cl2.  The reaction mixture was stirred overnight at –78 °C, diluted with 
3% Et3N in ether and filtered through a short plug of silica gel using 3% Et3N in ether. The 
filtrate was concentrated in vacuo and the crude product was purified by Kugelrohr distillation 
(pot temperature: 70–75 °C) at 75 mTorr to afford 2.10 g of the title compound (86%) as a 
colorless oil. Derivatization with benzylamine followed by the separation of the corresponding 
enantiomers on HPLC determined the enantiomeric excess to be 95.4%, using racemic sample as 
standard; [α]D = +23.2 (c 2.20, CHCl3); IR (thin film): 2955, 2929, 2884, 1830, 1472, 1256, 
1108, 837 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.69 (dddd, J = 10.4, 6.1, 4.4, 4.4 Hz, 1H), 3.79–
3.74 (m, 2H), 3.55 (dd, J = 16.4, 5.8 Hz, 1H), 3.21 (dd, J = 16.4, 4.3 Hz, 1H), 2.11–1.93 (m, 2 
H), 0.89 (s, 9H), 0.06 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 168.3, 69.0, 58.7, 43.1, 37.2, 25.7, 
18.1, –5.6; EI-MS e/v 173 (M+–tBu), 131 (M+–tBu–CH2CO), 101; HRMS calcd for C7H13O4: 
173.0634, found 173.0632. 
 
 
 (S)-5-(tert-Butyldimethylsilanyloxy)-3-methylpentanoic acid (103): To a       
–50 °C solution of 1.118 g of CuBr ( 7.79mmol) in 40 mL of THF and 6 mL of 
dimethylsulfide, was added 5.2 mL of methylmagnesiumbromide (15.6 mmol) 
(3 M solution in ether) slowly to give a yellow suspension. The suspension was allowed to warm 
to –30 °C and stirred at that temperature for 30 min. The reaction mixture was cooled back to     
–50 °C, and 1.200 g of the above lactone (5.19 mmol) in 6 mL of THF was added to it, and then 
HO
OTBS
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it was maintained at –50 °C for 45 min. Then, 0.9 mL (7.74 mmol) of trimethylsilylchloride was 
added to it and the reaction mixture was allowed to warm to ambient temperature overnight. It 
was quenched with 20 mL of a saturated aqueous solution of NH4Cl. After separation of the 
layers, the organic layer was washed twice with 30 mL of saturated NH4Cl solution and once 
with a saturated solution of EDTA. The combined aqueous layers were extracted with ether (5 x 
30 mL). The combined organics were dried over Na2SO4, concentrated in vacuo and the crude 
product was purified by flash chromatography (5% EtOAc in hexanes) to yield 0.993 g of the 
title compound (77%) as a pale yellow, viscous oil: [α]D = –1.5 (c 2.0, CHCl3); IR (thin film): 
3582, 2956, 2929, 2857, 1709, 1462, 1256, 1098, 835 cm-1; 1H NMR (300 MHz, CDCl3): δ 
3.75–3.64 (m, 2H), 2.41 (dd, J = 14.2, 5.1 Hz, 1H), 2.25–2.07 (m, 2H), 1.59 (dddd, J = 12.8, 6.8, 
6.8, 6.0 Hz, 1H), 0.47 (dddd, J = 13.4, 7.1, 6.3, 6.3 Hz, 1H), 0.99 (d, J = 6.5 Hz, 3H), 0.89 (s, 
9H), 0.05 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 179.4, 61.0, 41.5, 39.2, 27.2, 26.0, 19.8, 18.3,  
–5.4; EI-MS e/v 189 (M+–tBu), 171 (M+–tBu–H2O), 145 (M+–tBu–CO2), 127, 115; HRMS calcd 
for C8H17O3Si: 189.0947, found 189.0952. 
 
  
 (S)-[5-(tert-Butyldimethylsilanyloxy)-3-methylpentanoic acid 
methoxymethylamide (103a): To a solution of 2.05 g (8.29 mmol) of 
carboxylic acid 103 in 25 mL of  CH2Cl2 was added 1.21g of N,O-
dimethylhydroxylamine hydrochloride (12.4 mmol), 2.39 g of EDCI (12.4 mmol) and 1.53 g of 
DMAP (12.4 mmol). The resulting solution was stirred at ambient temperature for 2 h and 
quenched with 25 mL of brine. After separation of layers, the aqueous layer was extracted with 
EtOAc (5 x 25mL). The combined organics were dried over MgSO4 and the solvent evaporated 
N
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in vacuo. The crude product was purified by flash chromatography (10% EtOAc in hexanes) to 
obtain 2.145 g (90%) of the title compound as a colorless oil : [α]D = +7.5 (c 2.3, CHCl3); IR 
(thin film): 2956, 2857, 1669, 1463, 1411, 1384, 1255, 1095, 836  cm-1; 1H NMR (300 MHz, 
CDCl3): δ 3.67-3.56 (m, 2H), 3.62 (s, 3H), 3.14 (s, 3H), 2.40 (dd, J = 14.8, 5.6 Hz, 1H), 2.25 (dd, 
J = 14.3, 8.1 Hz, 1H), 2.18–2.07 (m, 1H), 1.57 (dddd, J = 13.4, 6.9, 6.9, 6.9 Hz, 1H), 1.39 (dddd, 
J = 13.7, 6.8, 6.8, 6.8 Hz, 1H), 0.92 (d, J = 6.6 Hz, 3H), 0.87 (s, 9H), 0.01 (s, 6H); 13C NMR (75 
MHz, CDCl3): δ 174.0, 77.3, 61.3, 61.1, 39.8, 39.2, 26.9, 25.9, 20.0, 18.3, –5.3; EI-MS e/v 274 
(M+–Me), 232, 158, 129; HRMS calcd for C13H28NO3Si: 274.1838, found 229.1839. 
 
 (S)-6-(tert-Butyldimethylsilanyloxy)-4-methylhexan-2-one (104): To a 0 °C 
solution of 0.64 g (2.19 mmol) of the above Weinreb amide in 20 mL of THF 
was added 1.8 mL (2.88 mmol) of a 1.6 M solution of methyllithium in ether. 
The resulting solution was warmed to ambient temperature and stirred for 15 min. The reaction 
was worked up by the addition of 30 mL of ether and 20 mL of water. After separation of the 
layers, the aqueous layer was extracted with ether (5 x 20 mL). The combined organics were 
dried over MgSO4   and the solvent was evaporated in vacuo. The crude product was purified by 
flash chromatography (4% EtOAc in hexanes) to obtain 0.490 g (91%) of the title compound as a 
colorless oil : [α]D = –4.7 (c 2.1, CHCl3); IR (thin film): 2956, 2927, 1718, 1471, 1255, 1093, 
836 cm-1; 1H NMR (300 MHz, CDCl3): δ 3.77–3.58 (m, 2H), 2.47 (dd, J = 15.3, 5.2 Hz, 1H), 
2.28-2.17 (m, 2H), 2.12 ( s, 3H), 1.52 (dddd, J = 12.7, 6.5, 6.5, 6.5 Hz, 1H), 1.39 (dddd, J = 
13.5, 6.6 Hz, 1H), 0.92 (d , J = 6.9 Hz, 3H), 0.89 (s, 9H), 0.05 (s, 6H); 13C NMR (75 MHz, 
CDCl3): δ 208.8, 60.9, 51.2, 39.5, 30.1, 26.2, 25.9, 19.8, 18.2, –5.4; EI-MS e/v 229 (M+–Me), 
Me
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187 (M+–tBu), 145 (M+–tBu–CH2CO), 115; HRMS calcd for C12H25O2Si: 229.1624, found 
229.1632. 
 
 (S)-(Trifluoromethanesulfonicacid-[4-(tert-butyldimethylsilanyloxy)-2-
methylbutyl]-vinyl ester (105): To a –78 °C solution of 18.6 mL of a 0.5 M 
solution of potassium bis(trimethylsilyl)amide in toluene (9.29 mmol) in THF 
(10 mL) was added a solution of 1.89 g of ketone 104 (7.74 mmol) in THF (18 mL), dropwise. 
The resulting solution was stirred at –78 °C for 15 min and then, a solution of 3.87 g (10.8 
mmol) of N-phenyltriflimide in THF (20 mL) was cannulated into the reaction mixture to 
produce a yellow solution which was then allowed to warm to 0 °C. Then, 30 mL of a saturated 
NaHCO3 solution and 35 mL of ether were added to it, the layers were separated, and the 
aqueous layer washed with ether (5 x 30 mL). The combined organics were dried over Na2SO4, 
concentrated and purified by column chromatography over silica gel (0.5% EtOAc in hexanes, 
2% Et3N) to afford 2.58 g (89%) of the title compound as a colorless oil; [α]D = –5.18 (c 2.04, 
CHCl3); IR (thin film): 2957, 2931, 2857, 1669, 1420, 1211, 1141 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 5.14 (d, J = 3.4 Hz, 1H), 4.95 (d, J = 3.4 Hz, 1H), 3.73–3.57 ( m, 2H), 2.40 (dd, J = 
15.3, 6.2 Hz, 1H), 2.15 (dd, J = 15.2, 7.9 Hz, 1H), 2.01–1.92 (m, 1H), 1.63 (dddd, J = 12.3, 6.8, 
5.1, 5.1 Hz, 1H), 1.37 (dddd, J = 11.7, 8.1, 5.8, 5.8 Hz, 1H), 0.97 (d, J = 6.6 Hz, 3H), 0.91 (s, 
9H), 0.06 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 155.7, 118.5 (JC-F = 318.2 Hz), 105.3, 60.6, 
41.5, 38.9, 26.9, 25.8, 18.9, 18.2, –5.4; EI-MS e/v 319 (M+–tBu), 291, 227; HRMS calcd for 
C16H28O4F3: 319.0647, found: 319.0653.   
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 (S)-4,4,5,5-Tetramethyl-2-[1-(2-methyl-4-trimethylsilanyloxy-butyl)-vinyl]-
[1,3,2]dioxaborolane (106): A mixture of 0.300 g of triflate 105 (0.802 mmol), 
0.224 g of bis(pinacolato)diboron (0.882 mmol), 0.056 g of 
bis(triphenylphosphine)palladium dichloride (0.088 mmol), 0.042 g of triphenylphosphine (0.160 
mmol) and 0.154g of potassium phenoxide (1.20 mmol) in 5 mL of toluene (0.2 M) was heated 
at 50 °C for 3 h. After cooling the reaction mixture to ambient temperature, added 2mL of water, 
20 mL of ether, separated the layers and extracted the aqueous layer with ether (3 x 10 mL). The 
organics were combined, dried over Na2SO4, concentrated and and the crude product purified by 
column chromatography over silica gel (2% EtOAc in hexanes, 1% Et3N) to afford 0.225 g 
(79%) of the title compound as a colorless oil; [α]D = –3.39 (c 2.25, CHCl3); IR (thin film): 2977, 
2957, 2857, 1614, 1427, 1370, 1308, 1255, 144, 1096 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.80 
(d, J = 3.6 Hz, 1H), 5.56 (d, J = 3.3 Hz, 1H). 3.70–3.58 (m, 2H), 2.18 (dd, J = 13.0, 6.0 Hz, 1H), 
1.95 (dd, J = 13.0, 7.8 Hz, 1H), 1.80–1.71 (m, 1H), 1.60 (dddd, J  = 13.1, 7.3, 5.2.5.2 Hz, 1H), 
1.33–1.24 (m, 1H), 1.25 (s, 12H), 0.89 (s, 9H), 0.83 (d, J = 6.6 Hz, 3H), 0.04 (s, 6H); 13C NMR 
(75 MHz, CDCl3): δ 130.3, 83.2, 77.4, 61.5, 43.3, 39.8, 29.4, 25.9, 24.7, 19.4, 18.3, –5.3; EI-MS 
e/v  297 (M+–tBu), 197, 169, 155; HRMS calcd for C15H30 BO3Si: 297.2057, found: 297.2055. 
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 (R)-3-Methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-hex-5-enal 
(106b): To a solution of 0.420 g of boronic ester 106 in THF (12 mL) was added 
a 1 M solution of tetrabutyl ammonium fluoride in THF at ambient temperature 
and the reaction mixture was stirred overnight. To this was added 20 mL of ether and 5 mL of 
NaHCO3 and after separation of the layers, the organic layer was washed with 5 mL of brine and 
O
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the aqueous layers were extracted with ether (5 x 20 mL). The combined organics were dried 
over Na2SO4, concentrated and and the crude product taken over to the next step without 
purification. To a 0 °C solution of the crude alcohol in 5 mL of CH2Cl2 was added a freshly 
prepared solution of 1.51 g of Dess-Martin periodinane in 1.7 mL of pyridine and 7mL of 
CH2Cl2.  The reaction mixture was allowed to warm to ambient temperature and stirred for 3 h. It 
was then diluted with pentane and filtered through a short plug of florisil. The filtrate was 
concentrated and purified by column chromatography (8% ether in pentane) to afford 0.200 g of 
the title compound (70%); [α]D = +6.85 (c 1.08, CHCl3); IR (thin film): 2978, 2930, 2716, 1726, 
1615, 1370, 1311, 1143, 861 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.75 (dd, J = 2.1 Hz, 1H), 
5.87 (d, J  = 3.3 Hz, 1H), 5.61 (s, 1H), 2.42 (ddd, J = 15.7, 4.7, 1.7 Hz, 1H), 2.28–2.23 (m, 1H), 
2.19–2.12 (m, 3H), 1.27 (s, 12H), 0.94 (d, J = 6.4 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 203.3, 
131.5, 83.5, 77.2, 50.4, 42.9, 28.1, 24.7, 20.5; HRMS calcd for C13H23BO3: 238.174, found: 
238.1741. 
 
 (S,E)-5-Methyl-7-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-octa-
2,7-dienoic acid ethyl ester (106c):   To a 0 °C suspension of 0.161 g of 
NaH (4.03 mmol) in THF (0.5 mL), was added 0.85 ml of 
diisopropyl(ethoxycarbonylmethyl) phosphonate (3.36 mmol). This was stirred at 0 °C for 20 
min and a solution of aldehyde 106b in THF (2.3 mL) was added to it. The reaction mixture was 
allowed to warm to ambient temperature, and then, 3 mL H2O was added to it, the layers were 
separated and the aqueous layer was washed with EtOAc (3 x 10 mL). The organics were 
combined and concentrated and the crude material was purified by flash chromatography (4% 
Me
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EtOAc/Hex) to yield 0.230 g (88%) of the title compound as a yellow oil: [α]D = –7.6 (c 2.4, 
CHCl3); IR (thin film) 2978, 2926, 2854, 1722, 1653, 1369, 1310, 1204, 1143 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 6.96 (ddd, J = 14.8, 7.5, 7.1 Hz, 1H), 5.84 (d, J = 3.5 Hz, 1H), 5.83 (ddd, J 
= 15.6, 1.4, 1.4 Hz, 1H), 5.58 (d, J = 3.3 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 2.29–2.13 (m, 2H), 
1.88–1.77 (m, 1H), 1.29 (t, J = 5.2 Hz, 3H), 1.26 (s, 12H), 0.86 (d, J = 6.6 Hz, 3H); 13C NMR 
(75 MHz, CDCl3): δ 166.7, 148.5, 130.9, 122.3, 83.4, 77.4, 60.1, 42.9, 39.2, 32.2, 24.7, 19.4, 
14.3; HRMS calcd for C17H29BO4: 308.2159, found 308.2159. 
 
 (S)-5-Methyl-7-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-octa-2,7-
dien-1-ol (107): To a –40 °C solution of 0.445 g of the above ester  in 9 mL 
of CH2Cl2 was added 2.7 mL of a 1.6 M solution of diisobutylaluminum 
hydride in hexanes and the reaction mixture was stirred at that temperature for 30 min.  It was 
quenched with a saturated solution of Rochelle’s salt and the resulting emulsion was allowed to 
clear by stirring for 1 h. The layers were separated and the aqueous layer was extracted with 
CH2Cl2 (3 x 20 mL). The combined organics were dried over Na2SO4, concentrated and and the 
crude product was purified by column chromatography (10–20% EtOAc/ Hex) to afford 0.350 g 
of allylic alcohol 107 (92%): [α]D = –4.85 (c 2.15, CHCl3); IR (thin film): 3377, 2977, 2923, 
1614, 1427, 1369, 1308, 1142, 970 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.89 (d, J = 3.6 Hz, 1H) 
5.68 (ddd, J = 15.4, 5.9, 5.9 Hz, 1H), 5.59 (ddd, J = 15.2, 4.6, 4.6 Hz, 1H), 5.55 (d, J = 2.9 Hz, 
H), 4.07 (app. d, J = 4.3 Hz, 2H), 2.17 (dd, J = 13.1, 6.2 Hz, 1H), 2.06 (ddd, J = 12.8, 5.4, 5.4 
Hz, 1H), 1.94 (dd, J = 13.2, 7.7 Hz, 1H), 1.88–1.77 (m, 1H), 1.75–1.61(m, 1H), 1.66 (s,1H), 1.25 
(s, 12H), 0.82 (d, J = 66 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 132.1, 130.5, 130.2, 83.4, 77.2, 
Me
Bpin
OH
 87 
63.8 42.7, 39.4, 32.8, 24.7, 19.4; HRMS calcd for (M++Na) C15H27BO3Na : 289.1951, found 
289.1968. 
 
2-[(E)-(S)-7-(tert-Butyldimethylsilanyloxy)-3-methyl-1-methylenehept-
5-enyl]-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (108): To a 0 °C 
solution of 0.134 g of allylic alcohol 107 (0.50 mmol) in 4 mL of DMF 
was added 0.038 g of imidazole (0.55 mmol, 1.1 equiv) and 0.091 g of tert-butyldimethylsilyl 
chloride (0.60 mmol, 1.2 equiv). The resulting solution was allowed to warm to ambient 
temperature and stirred for 8 h. It was quenched by the addition of 3 mL of brine and 10 mL of 
ether. After separation of the layers, the organic layer was washed with 5 mL of brine. The 
aqueous layers were extracted with ether (3 x 5 mL). The combined organics were dried over 
Na2SO4, concentrated and and the crude product purified by flash chromatography (5% EtOAc in 
hexanes) to afford 0.157 g of silyl ether 108 as a colorless oil (82%): [α]D = –3.7 (c 2.0, CHCl3); 
IR (thin film): 2956, 2928, 2857, 1614, 1462, 1370, 1254, 1144, 836 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 5.81 (d, J = 3.6 Hz, 1H), 5.67–5.47 (m, 3H), 4.13 (dd, J = 5.0, 1.0 Hz, 2H), 2.18 (dd, J 
= 13.1, 6.2 Hz, 1H), 2.08 (ddd, J = 13.4, 5.8, 5.8 Hz, 1H), 1.96 (dd, J = 13.1, 7.7 Hz, 1H), 1.83 
(ddd, J = 14.2, 7.4, 7.4 Hz, 1H), 1.74–1.65 (m, 1H), 1.26 (s, 12H), 0.90 (s, 9H), 0.83 (d, J = 6.5 
Hz, 3H), 0.07 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 130.5 (2 C), 130.1, 83.4, 77.5, 64.2, 42.8, 
39.4, 33.0, 26.1, 24.8, 19.3, 18.5, –4.9; HRMS calcd for C17H32BO3Si: 323.2214, found 
323.2202. 
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(E)-(3S,5R,10R)-3,5-Bis-(tert-butyldimethylsilanyloxy)-12-
hydroxy-5,6,10-trimethyl-8-methylene-dodec-6-enoic acid 
methoxy-methyl-amide (109): General procedure A was 
followed with 20 mg of iodide 90 (0.03 mmol), 23 mg of 
boronic ester 106a (0.09 mmol), 26 mg of Pd(CH3CN)2Cl2 (0.01, 30 mol %), 5.7 mg of dppf 
(0.01 mmol) and 32 mg of Ba(OH)2.8H2O (0.10 mmol, 3 equiv). Isolated 16 mg of diene 109 
(82%) as a colorless oil: [α]D = –41.6 (c 1.1, CHCl3); IR (thin film): 3443, 2954, 2928, 2856, 
1643, 1472, 1386, 1255, 1002, 834 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.94 (s, 1H), 5.01 (br s, 
1H), 4.82 (br s, 1H), 4.08 (dddd, J = 6.3, 6.3, 3.7, 3.7 Hz, 1H), 3.66 (s, 3H), 3.65–3.60 (m, 2H), 
3.40 (t, J = 6.5 Hz, 1H), 3.14 (s, 3H), 2.72 (d, J = 5.0 Hz, 2H), 2.17 (dd, J = 8.6, 3.0 Hz, 1H), 
1.95 (dd, J = 10.5, 3.6 Hz, 1H), 1.94–1.74 (m, 3H) 1.82 (s, 3H), 1.66–1.56 (m, 2H), 1.43 (s, 3H), 
0.91 (s, 9H), 0.85 (d, J = 6.2 Hz, 3H), 0.83 (s, 9H), 0.13 (s, 3H), 0.07 (s, 3H), 0.03 (s, 3H), –0.01 
(s, 3H); 13C NMR (75 MHz, CDCl3): δ 173.1, 145.4, 141.0, 125.8, 114.9, 78.3, 77.3, 67.7, 61.4, 
60.2, 49.2, 47.1, 40.9, 40.3, 31.9, 27.4, 26.4, 26.0, 18.8, 18.7, 15.8, –1.2, –1.7, –4.5, –4.7; HRMS 
calcd for (M++Na) C31H61NO4Si2Na: 594.3986, found 594.4088. 
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  (6E,12E)-(3S,5R,10S)-3,5,14-Tris-(tert-
butyldimethylsilanyloxy)-5,6,10-trimethyl-8-methylene-
tetradeca-6,12-dienoic acid methoxymethylamide (111): 
General procedure A was followed with 20 mg of iodide 90 
(0.03 mmol), 20 mg of boronic ester 108 (0.05 mmol), 26 mg of Pd(CH3CN)2Cl2 (0.01, 30 mol 
%), 5.7 mg of dppf (0.01 mmol) and 32 mg of Ba(OH)2.8H2O (0.10 mmol, 3 equiv). Isolated 23 
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mg of diene 108 (94%) as a colorless oil: [α]D = –4.9 (c 1.2, CHCl3); IR (thin film): 2955, 2928, 
2856, 1669, 1462, 1255, 1094, 835 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.88 (s, 1H), 5.57–5.53 
(m, 2H), 4.99 (s, 1H), 4.84 (s, 1H), 4.12 (d, J = 4.5 Hz, 2H), 3.66 (s, 3H), 3.14 (s, 3H), 2.65–2.63 
(m, 2H), 2.14–2.01 (m, 3H), 1.93–1.84 (m, 3H), 1.79 (s, 3H), 1.61 (dddd, J = 6.3, 6.3, 6.3, 6.3 
Hz, 1H), 0.91 (s, 9H), 0.90 (s, 9H), 0.84 (s, 9H), 0.83–0.81 (m, 3H), 0.12 (s, 3H), 0.07 (s, 6H), 
0.05 (s, 6H), 0.00 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 172.5, 145.0, 141.5, 130.6, 129.7, 
125.5, 114.6, 77.8, 67.2, 64.1, 61.2, 49.9, 45.5, 40.5, 39.4, 31.9, 31.5, 29.7, 28.6, 26.2, 26.0, 25.9, 
18.5, 18.4, 17.9, 15.0, –1.0, –1.4, –2.1, –4.5, –4.6, –5.1; HRMS calcd for (M++Na) 
C38H77NO5Si3Na: 734.5007, found 734.5005. 
 
 (2S,3S,5R)-{3-[2-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-
yl)-pent-4-enyl]-oxiranyl}-methanol (107a): To a –20 °C suspension of 
0.370 g of flame-dried, activated 4 Å molecular sieves in 2 mL of CH2Cl2 
was added a solution of 0.050 g of (+) diethyl tartarate (0.241 mmol) in 2 mL of CH2Cl2 
followed by 0.0445 mL of Ti(OiPr)4 (0.153 mmol) and 0.12 mL of  tert-butylhydroperoxide 
(0.602 mmol) dropwise, via syringe. After stirring the resulting white suspension for 30 min, a 
solution of 0.080 g of allylic alcohol 107 (0.300 mmol) in 3 mL of CH2Cl2 was added to it. The 
reaction mixture was stirred at –20 °C for 16 h and quenched with a freshly prepared solution of 
0.040 g of ferrous sulfate and 0.012 g of citric acid in 1 mL of water. After separation of the 
layers, the organic layer was filtered through a short plug of 1:1 celite/florisil, and the filter cake 
was washed with EtOAc. The aqueous layer was also extracted with EtOAc (3 x 5 mL). The 
combined organics were dried over Na2SO4, concentrated and and the crude product was purified 
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by medium pressure liquid chromatography (10–40% EtOAc/ Hex) to afford 0.057 g of epoxide 
107a (67%) as a colorless oil : [α]D = –16.3 (c 2.0, CHCl3); IR (thin film): 3436, 2977, 2950, 
1410, 1370, 1309, 1143, 862 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.83 (d, J = 3.4 Hz, 1H), 5.58 
(d, J = 3.1 Hz, 1H), 3.89 (ddd, J = 12.5, 5.0, 2.8 Hz, 1H), 3.65 (ddd, J = 11.4, 6.8, 4.3 Hz, 1H), 
2.99 (ddd, J = 5.9, 5.9, 2.3, 1H), 2.91 (ddd, J = 4.5, 2.6, 2.6 Hz, 1H), 2.21 (dd, J = 13.1, 6.3 Hz, 
1H), 2.03 (dd, J = 13.0, 7.6 Hz, 1H), 1.80-1.76 (m, 2H) 1.69 (ddd. J = 11.0, 5.6, 5.6 Hz, 1H), 
1.26 (s, 12H), 0.92 (d, 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 131.0, 83.4, 77.5, 61.7, 58.8, 
54.8, 43.1, 38.4, 30.6, 24.7, 19.6; HRMS calcd for C15H27BO4: 282.2002, found 282.1986. 
 
 (2S,3S,5R)-2-(1-{3-[3-(tert-Butyl-dimethyl-silanyloxymethyl)-
oxiranyl]-2-methyl-propyl}-vinyl)-4,4,5,5-tetramethyl-
[1,3,2]dioxaborolane (114): To a 0 °C solution of 0.045g of epoxy 
alcohol 107a (0.159 mmol) in 4 mL of DMF was added 0.033 g of imidazole (0.478 mmol) and 
0.072 g of tert-butyldimethylsilyl chloride (0.478 mmol). The resulting solution was allowed to 
warm to ambient temperature and stirred for 8 h. It was quenched by the addition of 3 mL of 
brine and 10 mL of ether. After separation of the layers, the organic layer was washed with 5 mL 
of brine. The aqueous layers were extracted with ether (3 x 5 mL). The combined organics were 
dried over Na2SO4, concentrated and and the crude product purified by flash chromatography 
(5% EtOAc in hexanes) to afford 0.054 g of silyl ether 114 as a colorless oil (86%): [α]D  = –7.46 
(c 0.45, CHCl3); IR (thin film): 2956, 2929, 2857, 1463, 1370, 1311, 1254, 1144, 1110, 837    
cm-1;   1H NMR (300 MHz, CDCl3): δ 5.83 (d, J = 3.2 Hz, 1H), 5.58 (br s, 1H), 3.78 (ddd, J = 
11.8, 2.3, 2.3 Hz, 1H), 3.67 (ddd, J = 12.6, 4.6, 4,6 Hz, 1H), 2.86-2.82 (m, 2H), 2.20 (dd, J = 
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13.2, 6.6 Hz, 1H), 2.04 (dd, J = 12.8, 7.5 Hz, 1H), 1.86 (dddd, J = 12.5, 6.3, 6.3, 6.3 Hz, 1H), 
1.73–1.65 (m, 2H), 1.26 (s, 12H), 0.92 (d, J = 6.6 Hz, 3H), 0.90 (s, 9H), 0.08 (s, 3H), 0.07 (s, 
3H); 13C NMR (75 MHz, CDCl3): δ 130.7, 83.3, 63.8, 59.1, 55.2, 43.2, 38.5, 30.6, 25.8, 24.7, 
19.4, 18.3, –5.3,   –5.4; HRMS calcd for (M++Na) C21H41BO4SiNa: 419.2765, found 419.2779. 
 
                                        (3S,5R,10R,12S,13S)-3,5-Bis-(tert-
butyldimethylsilanyloxy)-8-{3-[3-(tert-
butyldimethylsilanyloxymethyl)-oxiranyl]-2-methyl-
propyl}-5,6-dimethyl-nona-6,8-dienoic acid 
methoxymethylamide (115):General procedure A was followed with 19 mg of iodide 90 (0.032 
mmol), 20 mg of boronic ester 114 (0.050 mmol), 11 mg of palladium(dppf)dichloride (0.013 
mmol, 40 mol %) and 32 mg of barium hydroxide (0.096 mmol). Isolated  20 mg of the title 
compound as a pale yellow oil (80%): [α]D  = –7.25 (c 0.80, CHCl3); IR (thin film): 2955, 2928, 
2856, 1665, 1472, 1462, 1385, 1254, 835 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.90 (s, 1H), 5.01 
(s, 1H), 4.87 (s, 1H), 4.20–4.12 (m, 1H), 3.76 (ddd, J = 11.5, 3.0, 3.0 Hz, 1H), 3.70–3.59 (m, 
1H), 3.66 (s, 3H), 3.14 (s, 3H), 2.88–2.80 (m, 2H), 2.66–2.62 (m, 2H), 2.15 (dd, J = 12.9, 6.2 
Hz,1H), 1.98–1.85 (m, 4H), 1.79 (s, 3H), 1.78–1.64 (m, 2H), 1.52 (s, 3H), 0.93–0.90 (m, 3H), 
0.91 (s, 9H), 0.84 (s, 9H), 0.13 (s, 3H), 0.08 (s, 3H), 0.07 (s, 6H), 0.00 (s, 3H); 13C NMR (75 
MHz, CDCl3): δ 172.5, 144.6, 141.7, 125.4, 114.8, 77.9, 77.4, 67.3, 63.8, 61.2, 59.1, 55.1, 49.8, 
46.0, 40.5, 38.7, 30.3, 28.7, 26.2, 25.9, 19.5, 18.6, 18.3, 17.9, 15.0, –1.5, –2.0, –4.5, –5.3, –5.4; 
HRMS calcd for (M++Na) C38H77NO6Si3Na: 750.4956, found 750.4991. 
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(E)-(3S,5R,10R)-3,5-Bis-(tert-butyldimethylsilanyloxy)-11-
((2S,3S)-3-hydroxymethyl-oxiranyl)-5,6,10-trimethyl-8-
methylene-undec-6-enoic acid methoxymethylamide (115a): 
A 1.2 M solution of pyridine-buffered HF/Py was prepared as 
follows: To a 0 °C solution of 38 mg of silyl ether 115 (0.05 
mmol) in THF (4 mL) added 3.3mL of the above prepared HF/py solution (3.9 mmol, 80 equiv.) 
dropwise via syringe. Stirred the reaction mixture for 12 h at 0 °C, then diluted it with 20 mL of 
ether and added 5 mL of water to it. After separation of layers, extracted the aqueous layer with 
ether (5 x 5 mL) and dried the combined organics over Na2SO4. The solvents were evaporated in 
vacuo and the crude product  was purified by flash chromatography (2% Et3N, 10–30% EtOAc 
in hexanes) to afford 24 mg of the title product (75% yield) as a colorless oil: [α]D  = –27.2 (c 
1.70, CHCl3); IR (thin film): 3434, 2954, 2928, 2856, 1660, 1462, 1255, 1027, 834 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 5.95 (s, 1H), 5.04 (s, 1H), 4.84 (s, 1H), 4.07–4.00 (m, 1H), 3.88–
3.85 (m, 1H), 3.67 (s, 3H), 3.60 (dd,      J = 12.4, 4.6 Hz, 1H), 3.13 (s, 3H), 2.94–2.90 (m, 2H), 
2.76–2.61 (m, 2H), 2.23 (dd, J = 12.8, 3.8 Hz, 1H), 2.02–1.80 (m,  4H), 1.82 (s, 3H), 1.82–1.80 
(m, 2H), 1.43 (s, 3H), 0.93 (s, 9H), 0.92–0.89 (m, 3H), 0.82 (s, 9H), 0.15 (s, 3H), 0.09 (s, 3H), 
0.03 (s, 3H), –0.03 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 172.8, 144.6, 141.3, 125.0, 114.8, 
78.1, 77.4, 67.4, 62.4, 61.3, 58.8, 55.7, 49.6, 46.5, 40.4, 39.4, 31.9, 29.3, 26.3, 25.8, 19.3, 18.7, 
17.9, 15.4, –1.3, –1.7, –4.5, –4.8; HRMS calcd for (M++Na) C32H63NO6Si2Na: 636.4092, found 
636.4092. 
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(E)-(3S,5R,10R)-3,5-Bis-(tert-butyldimethylsilanyloxy)-11-
((2S,3R)-3-formyl-oxiranyl)-5,6,10-trimethyl-8-methylene-
undec-6-enoic acid methoxymethylamide (116): Dess-
Martin reagent in pyridine was prepared as follows: To a 
solution of 116 mg of Dess-Martin reagent (0.27 mmol, 12 
equiv.) in 0.4 mL of CH2Cl2, added 0.13 mL of pyridine (72 equiv). The resulting solution was 
stirred at ambient temperature for 2 minutes and the supernatant liquid was added via syringe 
into a 0 °C solution of 14 mg of alcohol 115a (0.022 mmol) in 0.2 mL of CH2Cl2. The resulting 
solution was allowed to warm to ambient temperature and stirred for 1.5 h. It was diluted with 
hexanes, filtered through a short plug of florisil, with 10% EtOAc in hexanes. After 
concentration in vacuo the crude product was purified by column chromatography (5% Et3N, 
then 5–10 % EtOAc in hexanes) to afford 9.8 mg of the title compound as a clear oil (70% 
yield): [α]D  = +9.6 (c 1.0, CHCl3); IR (thin film): 2928, 2855, 1731, 1659, 1462, 1384, 1254, 
1001, 834 cm-1; 1H NMR (300 MHz, CDCl3): δ 8.99 (d, J = 6.2 Hz, 1H), 5.92 (s, 1H), 5.02 (s, 
1H), 4.87 (s, 1H), 4.18–4.05 (m, 1H), 3.66 (s, 3H), 3.33 (dd, J = 5.8, 5.8 Hz, 1H), 3.13 (s, 3H), 
3.12–3.08 (m, 1H), 2.69–2.65 (m, 2H), 2.19 (dd, J = 12.7, 5.3 Hz, 1H), 2.05–1.90 (m, 3H), 1.80 
(s, 3H), 1.71–1.65 (m, 2H), 1.48 (s, 3H), 0.94 (d, J = 6.7 Hz, 3H), 0.91 (s, 9H), 0.83 (s, 9H), 0.14 
(s, 3H), 0.07 (s, 3H), 0.04 (s, 3H), –0.02 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 198.5, 172.5, 
144.3, 141.9, 125.3, 115.1, 78.0, 77.2, 67.4, 61.2, 59.6, 55.7, 49.6, 45.9, 40.5, 38.3, 31.9, 29.7, 
26.2, 25.8, 19.5, 18.6, 17.9, 15.2, –1.4, –1.9, –4.5, –4.6; EI-MS e/v 611, 596 (M+–Me), 554 (M+–
tBu); HRMS calcd for C28H52NO6Si2: 554.3333, found 554.3349. 
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 (E)-5-{(2S,3S)-3-[(E)-(2R,7R,9S)-7,9-Bis-(tert-
butyldimethylsilanyloxy)-10-
(methoxymethylcarbamoyl)-2,6,7-trimethyl-4-
ylene-dec-5-enyl]-oxiranyl}-2-methyl-pent-2-enoic 
acid 2-trimethylsilanylethyl ester (117): To a –55 °C 
solution of 51.3 mg of sulfone 65 (0.12 mmol, 8.0 equiv.) in DME (0.21 mL) added 0.26 mL of a 
0.5 M solution of potassium bistrimethylsilylamide in toluene (0.13 mmol, 8.7 equiv.). The 
resulting pale yellow solution was stirred for 30 min and then a solution of 9 mg of aldehyde 116 
(0.015 mmol) in 0.17 mL of DME was added to it to make the overall concentration 0.3 M w.r.t. 
sulfone 65. The solution was stirred at –55 °C for 2 h and warmed to ambient temperature over 2 
h. The reaction mixture was quenched by the addition of 1 mL of brine and 5 mL of ether. After 
separation of layers, the aqueous layer was extracted with ether (3 x 5 mL) and the combined 
organics were dried over Na
meth
2SO4. The solvents were evaporated in vacuo and the crude product 
was purified by flash chromatography (1% Et3N, then 5% EtOAc in hexanes) to afford 6 mg of 
the title compound (51% yield), a colorless oil, as a 2:1 mixture of E:Z isomers: [α]D  = –5.85 (c 
0.80, CHCl3); IR (thin film): 2954, 2928, 2855, 1709, 1665, 1462, 1252, 1116, 836 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 6.73 (dd, J = 5.6, 5.6 Hz, 1H), 5.90 (s, 1H), 5.91–5.87 (m, 1H), 5.23 
(dd, J = 15.5, 8.1 Hz, 1H), 5.00 (s, 1H), 4.87 (s, 1H), 4.24 (dd, J = 8.2, 8.2 Hz, 2H), 4.21–4.13 
(m, 1H), 3.66 (s, 3H), 3.14 (s, 3H), 3.02 (dd, J = 7.9, 2.9 Hz, 1H), 2.86–2.82 (m, 1H), 2.66–2.63 
(m, 2H), 2.28–2.13 (m, 5H), 1.96–1.88 (m, 3H), 1.83 (br s, 3H), 1.80 (s, 3H), 1.70–1.65 (m, 2H), 
1.45 (s, 3H), 1.04 (dd, J = 8.4, 8.4 Hz, 2H), 0.92 (d, J = 6.1 Hz, 3H), 0.91 (s, 9H), 0.84 (s, 9H), 
0.13 (s, 3H), 0.07 (s, 6H), 0.05 (s, 9H), 0.00 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 168.2 (2C), 
144.5, 141.7, 141.0, 140.4, 134.7, 128.6, 125.4, 114.9, 78.3, 77.2, 67.3, 62.7, 61.2, 59.0, 49.8, 
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46.0, 39.0, 31.2, 29.7, 29.4, 28.7, 28.1, 26.7, 25.8, 19.6, 18.6, 17.9, 17.3, 15.1, 12.4, –1.5 (2C), –
2.0, –4.5, –4.6; HRMS calcd for (M++Na) C44H83NO7Si3Na: 844.5375, found 844.5327. 
 
(E)-(3S,5R)-3,5-Bis-(tert-butyldimethylsilanyloxy)-7-iodo-5,6-
dimethyl-hept-6-enal (123): To a –78 °C solution of 0.160g of Weinreb 
amide 90 (027 mmol) in 0.6 mL of CH2Cl2 added 0.5 mL of diisobutylaluminum hydride (1 M 
solution in hexanes, 0.54 mmol) dropwise via syringe. The solution was stirred at –78 °C for 10 
min and then quenched with 10 mL of 0.2 M solution of HCl. The resulting turbid solution was 
allowed to stir for 1 h during which time it separated into clear layers. The layers were separated 
and the organic layer was filtered through a 1:1 mixture of celite: florisil. The aqueous layers 
were extracted with CH2Cl2 (5 x 10 mL). The combined organics were dried over Na2SO4 and 
the solvents were removed in vacuo. The crude product was purified by falsh chromatography 
(2% EtOAc in hexanes) to afford 0.129 g of aldehyde 123 (90%) as a clear oil: [α]D  = +3.0 (c 
1.3, CHCl3); IR (thin film): 2955, 2929, 2857, 1727, 1471, 1256, 1124, 1002, 836 cm-1; 1H NMR 
(300 MHz, CDCl3): δ  9.77 (dd, J = 3.1, 1.8 Hz, 1H), 6.36 (s, 1H), 4.12 (dddd, J = 11.8, 6.3, 4.6, 
4.6 Hz, 1H), 2.75 (ddd, J = 15.9, 4.4, 1.8 Hz, 1H), 2.46 (ddd, J = 15.9, 6.3, 3.2 Hz, 1H), 1.97 (dd, 
J = 14.4, 4.8 Hz, 1H), 1.87 (s, 3H), 1.83 (dd, J = 14.4, 7.4 Hz, 1H), 1.45 (s, 3H), 0.89 (s, 9H), 
0.85 (s, 9H), 0.12 (s, 3H), 0.07 (s, 3H), 0.05 (s, 3H), 0.04 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 
202.0, 151.0, 79.0, 78.7, 65.3, 52.0, 49.3, 28.7, 26.1, 25.8, 22.2, 18.5, 17.9, –1.6, –2.2, –4.2, –
4.4; HRMS calcd for (M++Na) C21H43O3Si2Na: 549.1693, found 549.1643. 
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 (E)-(4S,6R)-4,6-Bis-(tert-butyldimethylsilanyloxy)-8-iodo-1-(4-
methoxybenzyloxy)-6,7-dimethyl-oct-7-en-2-one (124): To a      
–78 °C solution of 70 mg of (paramethoxybenzyoxy)tributylstannane (0.16 mmol, 1.5 equiv) in 
0.4 mL of THF, was added 80 μL of BuLi (1.6 M solution in hexanes, 0.13 mmol, 1.2 equiv) and 
the solution was stirred for 20 min. To this was added a solution of 56 mg of aldehyde 123 (0.1 
mmol) in 0.35 mL of THF. The reaction mixture was stirred at –78 °C for 15 min and quenched 
with saturated NH4Cl solution. The layers were separated and the aqueous layer was extracted 
with ether (3 x 10 mL). The combined organics were dried over Na2SO4 and the solvents were 
evaporated in vacuo. The crude product was purified by flash chromatography (2–5% EtOAc in 
hexanes) and was dissolved in CH2Cl2 at 0 °C, to which 78 mg of Dess-Martin periodinane was 
added. The resulting solution was stirred for 3 h at ambient temperature, diluted with hexanes 
and filtered through a plug of florisil with 2% EtOAc in hexanes.The solvents were evaporated 
and the crude product purified by flash chromatography (2% EtOAc in hexanes) to afford 36 mg 
of the title compound (50%) as a colorless oil: [α]D  = +11.5 (c 1.90, CHCl3); IR (thin film): 
2954, 2929, 2856, 1720, 1612, 1514, 1251, 1093, 1002, 835 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 7.33–7.26 (m, 2H), 6.88 (d, J = 8.7, 2H), 6.31 (s, 1H), 4.52 (s, 2H), 4.14–4.09 (m, 1H), 3.98 (s, 
2H), 3.82 (s, 3H), 2.64 (dd, J = 15.7, 4.5 Hz, 1H), 2.54 (dd, J = 15.6, 7.3 Hz, 1H), 1.86 (s, 3H), 
1.83–1.79 (m, 2H), 1.44 (s, 3H), 0.88 (s, 9H), 0.83 (s, 9H), 0.11 (s, 3H), 0.05 (s, 3H), 0.04 (s, 
3H), 0.00 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 206.6, 159.5, 151.4, 129.6, 129.4, 113.9, 78.8, 
78.7, 75.5, 72.9, 65.8, 55.3, 49.5, 47.7, 28.5, 26.1, 25.9, 22.1, 18.5, 17.9, –1.6, –2.3, –4.3, –4.5; 
HRMS calcd for (M++Na) C30H53IO5Si2Na: 699.2374, found 699.2349. 
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 (2R,3R,5S)-5-(tert-Butyldimethylsilanyloxy)-3-methyl-hexane-1,2-diol 
(131a): To a 0 °C solution of 400 mg of epoxide 131 (1.6 mmol) in 6 mL of 
hexanes, added 2.5 mL of Me3Al (2 M solution in hexanes, 4.9 mmol, 3.0 equiv) dropwise. The 
resulting solution was warmed to ambient temperature and stirred for 1h. It was diluted with 
4mL of water, 4 mL of 0.2 M aqueous HCl solution and 10 mL of ether. The turbid white 
suspension was allowed to clear by stirring and then the layers were separated and the aqueous 
layer was extracted with ether (5 x 10 mL). The combined organics were dried over MgSO4 and 
concentrated. The crude product was purified by flash column chromatography (10–25% EtOAc 
in hexanes) to afford 350 mg of the title compound (83% yield) as  a colorless oil: [α]D = +28.9 
(c 1.30, CHCl3); IR (thin film): 3389, 2958, 2929, 2857, 1462, 1255, 1071, 835 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 3.90–3.85 (m, 1H), 3.64 (dd, J = 10.6, 2.4 Hz, 1H), 3.51–3.37 (m, 2H), 
3.17 (br s, 1H), 1.79–1.62 (m, 2H), 1.22–1.17 (m, 1H), 1.14 (d, J = 6.0 Hz, 3H), 0.90 (d, J = 4.6 
Hz, 3H), 0.87 (s, 9H), 0.07 (s, 3H), 0.05 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 76.7, 67.3, 65.0, 
42.9, 32.9, 26.1, 24.8, 18.1, 17.0, –4.0, –4.5; EI-MS e/v 231 (M+–Me–H2O), 205 (M+–tBu), 187,   
1 1 9 ,  9 9 ;  H R M S  c a l c d  f o r  C 1 2 H 2 7 O 2 S i :  2 3 1 . 1 7 8 0 ,  f o u n d                         
OTBS
OH
OH
231.1776.                                                                                                                                                                   
 
 
 (2R,3R,5S)-5-(tert-Butyldimethylsilanyloxy)-1-(4-methoxy-
benzyloxy)-3-methylhexan-2-ol (132): To a 0 °C suspension of 25 mg 
of NaH (1.0 mmol, 2.0 equiv) in THF (0.5 mL), added a solution of 80 mg of diol 131a (3.1 
mmol) in 1 mL of THF dropwise. The turbid white solution was allowed to warm to ambient 
temperature over 1h. Then, 57 mg of tetrabutylammonium bromide (1.5 mmol, 0.5 equiv) was 
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added followed by 60 mg of paramethoxybenzylbromide (3.7 mmol, 1.2 equiv) as a neat liquid. 
The resulting solution was stirred at ambient temperature for 24 h. The reaction mixture was 
diluted with 15 mL of ether and 5 mL of water. The layers were separated; the aqueous layer was 
extracted with ether (5 x 10 mL) and the combined organics were dried over MgSO4. After 
evaporation of the solvent in vacuo the crude product was purified by flash chromatography     
(5–10 % EtOAc in hexanes) to afford 75 mg of the title compound (64% yield) as a colorless oil: 
[α]D = +13.8 (c 1.30, CHCl3); IR (thin film): 3466, 2956, 2928, 2856, 1613, 1514, 1249, 1078, 
835 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.27 (d, J = 8.4 Hz, 2H), 6.89 (d, J = 8.6 Hz, 2H), 4.49 
(s, 2H), 3.94–3.84 (m, 1H), 3.81 (s, 3H), 3.62 (ddd, J = 8.3, 5.6, 2.6 Hz, 1H), 3.51 (dd, J = 9.4, 
2.9 Hz, 1H), 3.44–3.38 (m, 1H), 1.88–1.79 (m, 1H), 2.51 (s, 1H), 1.66 (ddd, J = 13.2, 9.3, 3.3 
Hz, 1H), 1.15 (d, J = 6.0 Hz, 3H), 0.91 (d, J = 7.0 Hz, 3H), 0.89 (s, 9H), 0.07 (s, 3H), 0.05 (s, 
3H); 13C NMR (75 MHz, CDCl3): δ  159.1, 130.1, 129.3, 113.8, 74.7, 73.0, 72.4, 66.3, 55.2, 
42.2, 32.2, 25.9, 24.6, 18.0, 16.0, –4.1, –4.8; HRMS calcd for (M++Na) C21H38O4SiNa : 
405.2437 found 405.2415. 
 
 (2S,3R,5S)-5-(tert-Butyldimethylsilanyloxy)-1-(4-methoxy-
benzyloxy)-3-methylhexan-2-ol (133): To a solution of 280 mg of 
alcohol 132 (0.7 mmol) in 7.4 mL of toluene (0.1 M) added 584 mg of triphenylphosphine (2.2 
mmol, 3.0 equiv), 371 mg of p-nitrobenzoic acid (2.2 mmol, 3.0 equiv) and 0.45 mL of 
diisopropylazadicarboxylate (2.2 mmol, 3.0 equiv). The resulting solution was allowed to stir at 
ambient temperature for 1 h, following which it was diluted with 20 mL of ether and 10 mL of 
brine solution was added to it. The organic layer was separated and washed with saturated 
NaHCO3 solution. The aqueous layers were extracted with ether (5 x 20 mL) and the combined 
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organics were dried over MgSO4. After evaporation of the solvents in vacuo, the crude product 
was purified by flash chromatography to give 380 mg of the benzoate ester that was saponified 
by the addition of 10 mL of a 1% solution of NaOH in MeOH. After stirring for 2 h, the solution 
was concentrated. To gave a white solid that was dissolved in ether (10 mL) and saturated 
NaHCO3 solution (5 mL). After separation of layers, the aqueous layer was extracted with ether 
(5 x 20 mL).  The crude product obtained after evaporation of the solvent was purified by flash 
chromatography (3–5% EtOAc in hexanes) to afford 241 mg of the title compound  (86% overall 
yield) as a colorless oil: [α]D = +20 (c 1.1, CHCl3); IR (thin film): 3466, 2957, 2929, 2856, 1613, 
1514, 1249,  1074, 835 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.29 (d, J = 8.5 Hz, 2H), 6.90 (d, J 
= 8.5 Hz, 2H), 4.50 (s, 2H), 3.96–3.88 (m, 1H), 3.82 (s, 3H), 3.68 (ddd, J = 8.1, 4.1, 3.3 Hz, 1H), 
3.53 (dd, J = 9.4, 3.3 Hz, 1H), 3.41 (dd, J = 8.9, 8.9 Hz, 1H), 2.47 (br s, 1H), 1.82–1.78 (m, 1H), 
1.55 (ddd, J = 8.4, 4.3, 3.9 Hz, 1H), 1.28–1.18 (m, 1H), 1.15 (d, J = 6.0 Hz, 3H), 0.93 (d, J = 6.8 
Hz, 3H), 0.91 (s, 9H), 0.09 (s, 3H), 0.06 (s, 3H); 13C NMR (75 MHz, CDCl3): δ  159.1, 130.0, 
129.3, 113.7, 73.9, 72.9, 72.8, 66.1, 55.1, 43.5, 31.9, 25.8, 24.6, 17.9, 14.1, –4.1, –4.8; HRMS 
calcd for (M++Na) C21H38O4Si : 405.2437 found 405.2415. 
 
 
[(1S,3R,4S)-4-Benzyloxy-5-(4-methoxybenzyloxy)-1,3-dimethyl-
pentyloxy]-tert-butyldimethylsilane (133a): To a 0 °C suspension of 
118 mg of sodium hydride (2.9 mmol, 4.0 equiv) in 1 mL of THF added a solution of 280 mg of 
alcohol 133 (0.7 mmol) in 2.7 mL of THF. The resulting solution was allowed to warm to 
ambient temperature stirred for 30 min. Then, 136 mg of tetrabutylammonium bromide (1.5 
mmol, 0.5 equiv) was added followed by 0.35 mL of benzylbromide (2.9 mmol, 4.0 equiv) as a 
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neat liquid. The resulting solution was stirred at ambient temperature overnight. The reaction 
mixture was diluted with 15 mL of ether and 5 mL of water. The layers were separated, and the 
organic layer was washed with 5 mL of brine solution. The aqueous layer was then extracted 
with ether (5 x 10 mL) and the combined organics were dried over MgSO4. After evaporation of 
the solvent in vacuo the crude product was purified by flash chromatography (2% EtOAc in 
hexanes) to afford 310 mg of the title compound (90% yield) as a colorless oil: [α]D = +9.9 (c 
1.6, CHCl3); IR (thin film): 3030, 2956, 2929, 2898, 2855, 1612, 1513, 1301, 1248, 1172, 1074, 
835 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.36–7.22 (m, 7H), 6.84 (ddd, J = 8.7, 2.5, 2.5 Hz, 
2H), 4.70 (d, J = 11.8 Hz, 1H), 4.56 (d, J = 12.2 Hz, 1H), 4.47–4.45 (m, 2H), 3.91–3.85 (m, 1H), 
3.79 (s, 3H), 3.57–3.55 (m, 1H), 3.49–3.45 (m, 1H), 2.00 (ddd, J = 10.2, 7.0, 3.6 Hz, 1H), 1.59 
(ddd, J = 13.2, 9.2, 3.5 Hz, 1H), 1.20 (ddd, J = 13.4, 9.9, 3.3 Hz, 1H), 1.12 (d, J = 6.0 Hz, 3H), 
1.08–1.03 (m, 1H), 0.90 (d, J = 6.9 Hz, 3H), 0.88 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H); 13C NMR 
(75 MHz, CDCl3): δ  159.2, 139.4, 130.7, 129.3, 128.6, 128.3, 127.9, 127.7, 127.4, 113.9, 82.7, 
73.1, 72.7, 71.8, 66.3, 55.4, 43.5, 31.4, 26.1, 24.9, 18.2, 14.6, –3.9, –4.6; HRMS calcd for 
(M++Na) C28H44O4Si : 495.2907 found 495.2909. 
 
 
 (2S,3R,5S)-2-Benzyloxy-5-(tert-butyldimethylsilanyloxy)-3-
methylhexan-1-ol (133b): To a solution of 55 mg of 
paramethoxybenzylether 133a (0.1 mmol) in a 10:1 CH2Cl2-H2O solvent mixture (1.1 mL), was 
added 26 mg of DDQ (0.1 mmol) at ambient temperature. The mixture was stirred for 1 h and 
then the solvents were evaporated in vacuo and the crude product was purified by flash 
chromatography (5–20% EtOAc in hexanes) to afford 31 mg of the title compound (75% yield) 
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as a colorless oil: [α]D = +49.6 (c 1.0, CHCl3); IR (thin film): 3434, 2957, 2929, 2883, 2856, 
1496, 1255, 1074, 835 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.37–7.27 (m, 5H), 4.70 (d, J = 11.3 
Hz, 1H), 4.49 (d, J = 11.3 Hz, 1H), 3.94–3.87 (m, 2H), 3.69–3.59 (m, 2H), 3.43 (ddd, J = 8.3, 
7.5, 4.2 Hz, 1H), 2.22–2.12 (m, 1H), 1.96 (br s, 1H), 1.70 (ddd, J = 12.9, 9.7, 2.7 Hz, 1H), 1.16 
(d, J = 6.0 Hz, 3H), 0.95 (d, J = 7.0 Hz, 3H), 0.90 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H); 13C NMR 
(75 MHz, CDCl3): δ  138.5, 128.4, 127.8, 127.7, 84.1, 71.8, 66.0, 62.2, 41.8, 29.7, 25.9, 24.8, 
18.0, 15.3, –4.1, –4.8; HRMS calcd for (M++Na) C20H36O3SiNa : 375.2331 found 375.2332. 
 
 
 (2S,3R,5S)-2-Benzyloxy-5-(tert-butyldimethylsilanyloxy)-3-
methylhexanal (130): To a –78 ° C solution of 12 μL of oxalyl chloride in 
0.4 mL of CH2Cl2 added 20 μL of DMSO dropwise. The turbid solution was stirred at –78 °C for 
10 min and then a solution of 30 mg of alcohol 133b in 0.4 mL of CH2Cl2 was added and the 
resulting solution was stirred at –78 °C for 30 min following which 70 μL of DIPEA was added. 
After stirring at –78 °C for 10 min it was warmed to ambient temperature over 30 min. The 
reaction was worked up by the addition of 2 mL of ether and 3 mL of saturated ammonium 
chloride solution. After separation of layers, the aqueous layer was extracted with ether (3 x 5 
mL). The combined organics were dried over Na2SO4 and evaporated in vacuo. The crude 
product was purified by column chromatography (5% EtOAc in hexanes) on Iatrobeads to isolate 
26 mg of the title compound (84% yield): [α]D = –15.4 (c 0.61, CHCl3); IR (thin film): 2958, 
2929, 2856, 1732, 1462, 1255, 1131, 1075, 835 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.67 (d, J = 
2.2 Hz, 1H), 7.37–7.33 (m, 5H), 4.70 (d, J = 11.7 Hz, 1H), 4.52 (d, J = 11.7 Hz, 1H), 3.89 (ddq, 
J = 9.3, 2.6, 2.6 Hz, 1H), 3.62 (dd, J = 4.6, 2.6 Hz, 1H), 2.30–2.20 (m, 1H), 1.57 (ddd, J = 13.5, 
CHO
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9.4, 4.1 Hz, 1H), 1.30 (ddd, J = 13.4, 9.9, 3.3 Hz, 1H), 1.14 (d, J = 6.0 Hz, 3H), 0.97 (d, J = 6.9 
Hz, 3H), 0.89 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H); 13C NMR (75 MHz, CDCl3): δ  204.2, 137.6, 
128.4, 128.2, 127.9, 87.6, 72.7, 65.9, 42.8, 31.2, 25.9, 24.6, 18.0, 14.2, –4.1, –4.8; HRMS calcd 
for (M++Na) C20H34O3Si : 373.2175 found 373.2179. 
 
 
(3S,5R)-3,5-Bis-(tert-butyldimethylsilanyloxy)-5-methyl-7-
trimethylsilanyl-hept-6-ynal (86b): To a –78 °C solution of 0.160 g 
of Weinreb amide 86a (0.31 mmol) in 0.7 mL of CH2Cl2 added 0.62 mL of diisobutylaliminum 
hydride (1 M solution in hexanes, 0.62 mmol) dropwise via syringe. The solution was stirred at –
78 °C for 10 min and then quenched with 10 mL of 0.2 M solution of HCl. The resulting turbid 
solution was allowed to stir for 1 h during which time it separated into clear layers. The layers 
were separated and the organic layer was filtered through a 1:1 mixture of celite: florisil. The 
aqueous layers were extracted with CH2Cl2 (5 x 10 mL). The combined organics were dried over 
Na2SO4 and the solvents were removed in vacuo. The crude product was purified by flash 
chromatography (2% EtOAc in hexanes) to afford 0.124 g of aldehyde 86b (88%) as a clear oil: 
[α]D = +8.3 (c 1.0, CHCl3); IR (thin film): 2956, 2930, 2857, 2710, 2166, 1729, 1472, 1252, 
1114, 838 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.81 (dd, J = 3.2, 2.1 Hz, 1H), 4.58 (dddd, J = 
10.3, 7.6, 5.9, 3.0 Hz, 1H), 2.87 (ddd, J = 15.9, 2.6, 1.8 Hz, 1H), 2.58 (ddd, J = 10.9, 7.6, 3.2 Hz, 
1H), 1.98 (dd, J = 14.0, 9.4 Hz, 1H), 1.81 (dd, J = 13.8, 2.6 Hz, 1H), 1.46 (s, 3H), 0.86 (s, 9H), 
0.84 (s, 9H), 0.21 (s, 3H), 0.18 (s, 9H), 0.16 (s, 3H), 0.13 (s, 3H), 0.09 (s, 3H); 13C NMR (75 
MHz, CDCl3): δ  202.8, 108.9, 89.7, 68.4, 66.6, 52.1, 32.5, 25.7 (2C), 17.9, 17.8, –0.3, –2.9, –
3.1, –4.1, –4.7; HRMS calcd for (M++Na) C23H48O3Si3 : 479.2809, found 479.2811. 
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 2-[(2S,4R)-2,4-Bis-(tert-butyldimethylsilanyloxy)-4-methyl-6-
trimethylsilanyl-hex-5-ynyl]-[1,3]dithiane (129): To a –10 °C 
solution of 60 mg of aldehyde 86b (0.130 mmol) and 17 mg of 1, 3-propanedithiol (0.16 mmol, 
1.2 equiv) in 1 mL of CH2Cl2 was added 13 μL of titanium tetrachloride (1 M solution in 
CH2Cl2, 0.013 mmol, 0.1 equiv). The resulting solution was allowed to warm to ambient 
temperature and stirred for 1 h. It was then quenched with saturated NH4Cl solution and the 
layers were separated. The aqueous layer was extracted with ether (3 x 5 mL). The combined 
organics were dried over MgSO4 and the solvents were evaporated in vacuo. The crude product 
was purified by flash chromatography (1% EtOAc in hexanes) to afford 44 mg of dithiane 129 
(61%) as a clear oil: [α]D = +31.7 (c 0.606, CHCl3); IR (thin film): 2956, 2929, 2856, 2165, 
1472, 1252, 1123, 989, 837 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.30 (dddd, J = 12.1, 8.1, 6.5, 
3.8 Hz, 1H), 4.17 (dd, J = 11.2, 3.3 Hz, 1H), 2.95–2.69 (m, 4H), 2.32 (ddd, J = 14.1, 11.3, 2.7 
Hz, 1H), 2.14–2.04 (m, 1H), 1.95–1.67 (m, 4H), 1.43 (s, 3H), 0.90 (s, 9H), 0.87 (s, 9H), 0.23 (s, 
3H), 0.21 (s, 3H), 0.19 (s, 9H), 0.15 (s, 3H), 0.12 (s, 3H); 13C NMR (75 MHz, CDCl3): δ  109.1, 
89.4, 77.2, 68.0, 67.1, 52.6, 44.8, 43.7, 32.5, 30.9, 30.1, 25.9, 25.8, 18.0, 17.9, –0.2, –2.7, –2.8, –
4.0, –4.5; HRMS calcd for C26H54O2Si3S2: 546.2873, found 546.2866. 
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